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As part of an ongoing exploration of marine invertebrates as a source of new antimicrobial 
peptides, hemocyte extracts from the red king crab, Paralithodes camtschaticus were studied. 
Three cationic cysteine (Cys)-rich peptides, named paralithocins 1-3, were isolated by bioassay 
guided purification and their amino acid sequences determined by Edman degradation and 
expressed sequences tag analysis. Disulfide bond mapping was performed by high resolution 
tandem mass spectrometry. The peptides (38-51 amino acids in length) share a unique Cys motif 
composed of eight Cys, forming four disulfide bridges with a bond connectivity of (Cys relative 
position) Cys1-Cys8, Cys2-Cys6, Cys3-Cys5, and Cys4-Cys7, a disulfide arrangement that has 
not been previously reported among antimicrobial peptides. Thus, paralithocins 1-3 may be 
assigned to a previously unknown family of antimicrobial peptides within the group of Cys-
rich antimicrobial peptides. Although none of the isolated peptides displayed antimicrobial 
activity against the target strains Escherichia coli, Pseudomonas aeruginosa or Staphylococcus 
aureus, they inhibited the growth of several marine bacterial strains with minimal inhibitory 
concentrations (MIC) in the 12.5-100 µM range. These findings corroborate the hypothesis that 







Antimicrobial peptides (AMPs) are oligopeptides that inhibit bacterial growth in vitro under 
physiological conditions. They are considered to be an important part of the innate immune 
system in all species, including vertebrates and invertebrates.1, 2 Due to their lack of T- and B-
cell repertoire, invertebrates depend on AMPs and other innate immune factors/mechanisms to 
combat invading pathogens. The importance of AMPs for survival during microbial challenge 
has been well documented in several invertebrate species, including the fruit fly, Drosophila 
melanogaster,3 the whiteleg shrimp, Litopenaeus vannamei,4-6 and the Pacific oyster 
Crassostrea gigas.7 Upon a microbial challenge, increased levels of AMPs are due to either 
increased ribosomal translation or cleavage of larger proteins (already present, having other 
physiological functions) of which the AMPs are an integral part.8, 9 Beside their function as 
genetically coded antimicrobials, evidence suggests that AMPs may alter membrane properties 
or interact with receptors to influence e.g. cytokine release, chemotaxis, wound healing, 
angiogenesis, and antigen presentation.10-12 
Most AMPs share some common features; they constitute less than 100 amino acids (aa), 
are positively charged, and amphipathic.13 A finer classification is challenging, but some broad 
groups exist: 1) amphipathic peptides with a linear α-helix structure; 2) peptides with β–sheets 
and/or extended or loop structures, often stabilized by disulfide bridges; 3) peptides with a high 
proportion of one or more aa (most often Pro, Arg, Gly, Trp, and/or His); and 4) peptides 
containing one or more D-aa and or modified aa (e.g. brominated Trp).10, 14 Marine invertebrates 
have proven to be a promising source for discovery of bioactive peptides and numerous AMPs 
have been characterized from crustacean hemolymph/hemocytes, most of them Cys-rich.15, 16 
Crustacea is an arthropod subphylum comprising a diverse group of animals, including species 
with both ecological and economic importance. In terms of AMPs, there has been a particular 




penaeidins, consisting of a Pro-Arg rich N-terminal region and a cysteine-containing C-terminal 
region, have only been detected in shrimp (Penaidae) species.18 The C-terminal part contains 
three disulfide bridges having a Cys motif of Cys1-Cys3, Cys2-Cys5, and Cys4-Cys6 (the italic 
numbers corresponds to the relative positions of Cys throughout the peptide chain).19, 20 The 
crustin peptide family is defined as AMPs of ca. 7-14 kDa in size, containing 8-12 Cys, with a 
characteristic four-disulfide core-containing whey acidic protein (WAP) domain in the C-
terminal part. In contrast to the penaeidins, the crustins seem to be widespread throughout the 
entire crustacean subphylum,21 and even present in other arthropod subphyla.22 In addition to 
penaeidins and crustins, numerous other AMPs have been discovered in crustaceans.15 
Recently, panusin, a β-defensin-like AMP containing six Cys with Cys1-Cys5, Cys2-Cys4, and 
Cys3-Cys6 connectivity was discovered.23 
 Although the disulfide bridges are not essential for biological activity in some disulfide-
containing AMPs,24-26 a stable tertiary structure is usually imperative for proper biological 
function and stability of disulfide-rich peptides.27 A peptide with n Cys have i possible 
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Determining the correct Cys pair bridging is crucial to predict the correct peptide tertiary 
structure. Three methods are commonly used in order to determine the disulfide connectivity; 
NMR analysis,28 X-ray crystallography,29 and Edman degradation,30 however, these techniques 
usually require a few mg of the sample material and peptides obtained from marine 
invertebrates are rarely isolated in such high amounts. Mass spectrometry (MS) is therefore a 




structure elucidation is more cumbersome compared to NMR and X-ray analysis, because 
manual interpretation of the spectra is required, especially if the peptide constitutes a 
undescribed Cys-rich motif. Several strategies can be used for disulfide connectivity 
determination by MS analysis either used alone or in combination with other techniques, as 
thoroughly reported by Tsai et al.:31 1) peptide profiles are compared before and after reduction; 
2) one or more partial reduction(s) and alkylation(s); 3) data analysis based on in silico 
algorithms; 4) in line reduction of Cys-Cys, and 5) labeling with disulfide selective reagents.  
 In a previous study,32 we detected antibacterial activity in various tissues and the 
hemocytes of the red king crab, Paralithodes camtschaticus. Later, the primary structure of a 
putative crustin AMP was described in the same species.16 Herein we report on the isolation 
and structure elucidation of three new AMPs, all containing four disulfide bridges, from the 
hemocytes of P. camtschaticus. The peptides were isolated through bioassay-guided 
purification and tested for activity against Gram negative and Gram positive bacteria. Their 
primary structures were partially elucidated through Edman amino acid sequencing and totally 
verified by comparison of mass spectrometry (MS/MS) data analysis of intact peptides with 
sequences of putative peptides derived from an expressed sequence tag (EST) library. Finally, 
the disulfide connectivity was elucidated by partial reduction and alkylation followed by high 





RESULTS AND DISCUSSION 
 
Isolation of Antimicrobial Peptides from P. camtschaticus Hemocytes. A previous 
screening for antibacterial activity in the red king crab, P. camtschaticus, showed that hemocyte 
extracts contain proteinaceous compounds that possess antibacterial activity in vitro.32 Herein 
we describe the purification and characterization of three new antibacterial peptides from the 
hemocytes of the king crab. An extract prepared from dried hemocytes was subjected to solid 
phase extraction (SPE). Elution was successively performed with 10, 40, and 80% solutions of 
MeCN in acidified H2O. Based on our previous results,32 and taking into account the amount 
of available material, we focused our attention on the 40% SPE fraction. This fraction, 
containing a total of 206 mg protein, was further fractionated by preparative reversed-phase 
high performance liquid chromatography (RP-HPLC) using a linear gradient of 0-40% MeCN. 
Several fractions (peaks) showed antibacterial activity against the Gram-positive bacterium 
Corynebacterium glutamicum and Gram-negative bacterium Listonella (Vibrio) anguillarum. 
The active peptides designated as P23, P30 and P34 (Figure 1) were purified to homogeneity 
and subjected for further analysis. As shown in Figure 1, these peptides (especially P23) 
constitute a major quantitative part of the compounds present in the 40% SPE eluate. Distinct 
UV absorbance at 280 nm during RP-HPLC (data not shown) suggests that the peptides contain 
tyrosine and/or tryptophan residues. 
 
Peptide Sequencing, Amino Acid Analysis and Mass Analysis. Partial primary 
structure determination was performed by Edman degradation. The partial N-terminal 
sequences for P23 (30 residues: WQQPSXSSIXDYSXGKSAXISYSGRXGXXA), P30 (30 




RSQPGPTXPSSVQAILXDNRXGRSAXSYY) revealed that all peptides contained several 
unidentified amino acids (denoted X), most likely Cys, but otherwise no apparent homology 
between each other. According to amino acid analyses (Table S1), all peptides contained Cys 
and more basic amino acids than negatively charged amino acids, i.e. they are cationic of nature. 
In addition, P23 was devoid of Thr, Val, His, Phe, and Leu, but rich in Ser (ca. 23 mol%). P30 
was devoid of His and Phe but rich in Pro (ca. 21 mol%), whereas P34 was devoid of Phe and 
relatively rich in Pro and Ser (ca. 11-16 mol% of both). The monoisotopic masses of the three 
peptides were determined by HRMS to be 4075.6248 (P23), 5045.1705 (P30), and 5559.4226 
Da (P34), respectively. However, in each of these peptide fractions, a mass 0.98 Da above the 
reported value (<10% abundance compared to the main peptide) was also observed. The 
peptides were named paralithocin 1 (P23), paralithocin 2 (P30), and paralithocin 3 (P34) after 






Figure 1. RP-HPLC profile of the 40% SPE eluate of a hemocyte extract from P. camtschatica. Peaks 
containing the paralithocins are labeled in the chromatogram. The dotted line shows the linear MeCN 
gradient (0-40%) dissolved in 0.1% TFA. The horizontal bars indicate fractions with antibacterial 
activity against L. anguillarum (dark grey) and C. glutamicum (hatched). 
 
 Identification of Genes and Complete Primary Structures. To identify the cDNA 
gene of the peptides, an EST library of the hemocytes was constructed and 384 randomly picked 
clones were sequenced and data from 374 were subjected to bioinformatic analyses. Cap3 
sequence analyses revealed that five of 16 contigs were more redundant than the other (Table 
S2). The longest cDNA clones of three of the contigs (contig 2, 16 and 11) were sequenced 
forward and backward and consensus sequences were established (Figure S1). All three 
sequences coded for a signal peptide of 23 amino acids and mature peptides containing eight 
Cys (Figure 2). The deduced mature peptides corresponded with the partial amino acid 
sequences of the isolated peptides. Consensus for contig 2 (40% redundancy) and contig 16 
(8% redundancy) contained open reading frames (ORF) of 62 and 71 amino acids, respectively 
(Figure S1A and B).  
 
 
Figure 2. Alignment of the deduced peptide sequences from the EST library (contigs 11, 2 and 16) from 
hemocytes of the red king crab, P. camtschatica. The mature part of the sequences are identified as 
mature 
1 2 3 4 5 6 7 8 
Con.11_para.3   MGPMKVLLVMLVVMVAAPHIADA 
Con.02_para.1   MGPMKVLLVLLVVMVAAPHIADA 
Con.16_para.2   MGAAKVLLVVLAVMVAVPNLAEG 
Con.11_para.3   RSQPGPTCPSSVQAILC-DNRCGRSACS-YYIERCACCAKCNRIPYYGASNHP  GR 
Con.02_para.1   WQQ--PSCSS-----IC-DYSCGKSACI-SYSGRCGCCASCRRGPIY        G 





paralithocins 3, 1 and 2, respectively. The alignment is done according to the eight cysteine arrays as 
indicated. Identical and strongly similar amino acids are shaded in black or grey, respectively. Pre-
sequences are marked as signal-sequences and the C-terminal amino acids not present in the mature 
paralithocins (G and GR) are boxed.  
 
 The putative mature peptides coded were 39 and 48 aa long with theoretical 
monoisotopic masses of 4133.63 and 5103.17 Da (with all Cys in oxidized forms), respectively. 
These values deviates from the measured masses of the isolated paralithicins 1 and 2 by +58 
Da, indicating the presence of additional modifications. Both sequences contain a C-terminal 
Gly residue, a target for peptidylglycine α-amidating monooxygenase (PAM), an enzyme 
contributing to C-terminal amidation of peptides.33, 34  Cleavage of the C-terminally Gly residue 
and subsequent C-terminal amidation of the deduced sequences, leads to theoretical 
monoisotopic masses of 4075.62 and 5045.17 Da, which corresponds to the measured masses 
of paralithocin 1 and 2, respectively. Contig 11 (4% redundancy) contained an ORF of 76 amino 
acids (Figure S1C), coding for a putative mature peptide of 53 aa with a calculated 
monoisotopic mass of 5773.53 Da. This mass is about 214 Da above the measured mass of 
paralithocin 3. However, enzymatic cleavage of the C-terminal residues Gly-Arg, first by an 
exopeptidase and secondly by PAM, leads to a C-terminally amidated peptide with a theoretical 
monoisotopic mass (5559.42 Da) that corresponds completely to the experimental 
monoisotopic mass of paralithocin 3. Post-translational cleavage of dipeptides C-terminally 
(like Gly-Arg in paralithocin 3) and subsequent C-terminal amidation has been described 
previously in various invertebrate AMPs.35-38 A top down MALDI-TOF MS/MS analysis 
approach confirmed that the native amino acid sequences were identical to the putative mature 




amino acids were not present in the native peptides. Masses observed at +0.98 Da can be 
explained by paralithocin analogues having a free acid C-terminally (Table S3). Natural 
mixtures of C-terminally amidated and non-amidated AMPs have been described before.39, 40  
Although the primary sequence and peptide length differ between the three mature peptides, 
there are some similarities. Firstly, all three peptides contain eight cysteine residues with a 
common cysteine pattern (C-C-C-C-C-CC-C) and sequence motif of CXCCXXC, indicating 
identical Cys connectivity. The isolated peptides are all cationic with isoelectric points (pI) of 
8.51 (paralithocin 1), 8.50 (paralithocin 2) and 8.73 (paralithocin 3). BLAST and homology 
searches of the obtained oligopeptide and nucleotide sequences resulted in no overall sequence 
similarity to other known peptides/proteins. Comparison of the Cys pattern in the primary 
structure of paralithocins with other AMPs containing eight Cys residues (searches performed 
against various antimicrobial peptide databases) revealed a unique Cys location pattern within 
the paralithocins (Table 1).  
 
Table 1. Antimicrobial Peptides Containing Four Disulfide Bridges. Adjacent Cysteines in the 
Cysteine Pattern Are Marked in Bold. 
Cysteine-
connectivity 
Cysteine pattern Representative 
peptide 
# aa Origin UniProt 
code/ref. 
1-2, 3-7, 4-8, 5-6 C-C-CCC-C-C-C Sillucin 30 Fungus P02885 
1-3, 2-4, 5-7, 6-8 C-C-C-C-C-C-C-C Gambicin 61 Insect Q9XZN6 
1-4, 2-5, 3-6, 7-8 C-C-CC-C-C-C-C PN-AMP1 (Hevein) 41 Plant P81591 
1-5, 2-6, 3-4, 7-8 C-C-C-C-C-C-C-C Antifungal protein 73 Fungus P17737 
1-5, 2-6, 3-7, 4-8 C-C-C-C-C-C-C-C MGD-1 38 Mussel P80571 
1-6, 2-3, 4-7, 5-8 C-C-CC-C-C-C-C LTP-1 91 Plant P07597 
1-6, 2-5, 3-7, 4-8 C-C-C-C-C-C-C-C Hydramacin-1 60 Cnidarian B3RFR8 




1-7, 2-6, 3-5, 4-8 C-C-C-C-C-C-C-C Locustin 55 Insect P83428 
1-8, 2-4, 3-6, 5-7 C-CC-CC-C-CC Hepcidin 25 Human P81172 
1-8, 2-5, 3-6, 4-7 C-C-C-C-C-C-C-C Drosomycin 44 Insect P41964 
1-8, 2-6, 3-5, 4-7 C-C-C-C-C-CC-C Paralithocin 1 38 Crustacean This study 
1-8, 2-7, 3-6, 4-5 CC-C-C-C-C-C-C Leaf-specific thionin 46 Plant P09617 
 
Paralithocin 1 showed 55.8% and 63.2% identity to paralithocin 2 and 3, respectively, 
at the cDNA level. The paralithocin transcripts have been submitted to NCBI GenBank with 
the accession numbers MF919584 (paralithocin 1), MF919585 (paralithocin 2), and MF919586 
(paralithocin 3), respectively. 
 
Determination of Disulfide Bridge Connectivity. Peptides containing intact disulfide 
bridges produce y- and b-ions upon collision induced dissociation (CID) through cleavage of 
peptide bonds of amino acids not enveloped within the disulfide knot. Occasionally, b- and y-
ions from Cys-Cys are observed as their [b/y ± H/SH] ions, but b- and y-ions formed by peptide 
bond cleavage of amino acids that exist within the disulfide knot are rarely observed. The 
strategy used in the present work was to conduct a partial reduction of the disulfide bonds and 
alkylation with N-ethylmaleimide (Nem), and to conduct CID experiments of the resulting 
peptides containing four, three, two, one, and no intact disulfides. The retention times of the 
partially reduced and alkylated peptides increased with their number of reduced and alkylated 
S–S bridges. This may be rationalized by the fact that the hydrophobic amino acids occupy the 
less water exposed interior of the intact peptides, but following reduction and alkylation, they 
were more exposed to the aqueous mobile phase used in reversed-phase chromatography, 
resulting in an increased non-polar surface area. Additionally, the alkylation itself introduces a 





The total ion chromatograms (TIC) of native, partially, and totally reduced and alkylated 
paralithocin 1 is shown in Figure S2 and only one isomer of each reduced and alkyled peptide 
was observed. For native paralithocin 1, CID of [M+5H]5+ (m/z 816.3287, ∆m = –0.7 ppm) y1+-











Figure 3. HRMS/MS spectra of (a) native paralithocin 1 (P23) [M +5H]5+ at m/z 816.3287, (b) 
paralithocin 1 with one reduced and alkylated Cys-Cys bond [M +5H]5+ at m/z 866.7509, (c) paralithocin 
1 with two reduced and alkylated Cys-Cys bonds [M +5H]5+ at m/z 917.1749, (d) paralithocin 1 with 
three reduced and alkylated Cys-Cys bonds [M +5H]5+ at m/z 967.5953, and (e) paralithocin 1 with all 
Cys-Cys bonds reduced and alkylated [M +5H]5+ at m/z 1018.0175. 
 
Furthermore, y363+#, y353+, y343+, and y333+ were observed (# indicates additional loss of 
ammonia), as well as (y32+SH)3+, all in support for a Cys6. More ions were recorded upon CID 
of paralithocin 1 where one Cys-Cys was reduced and alkylated ([M+5H]5+ was observed at 
m/z 866.7509; Figure 3b). A complete series of y1+ to y5+ and y62+ to y92+ ions were recorded, 
indicating a reduction/alkylation of Cys32 (Cys32-Nem). From the N-terminal end, the y374+ #-
y354+ #, and y353+-y293+ ions were all observed, which indicated Cys6-Nem. Thus, these 
observations suggest a Cys6-Cys32 (Cys1-Cys8) disulfide bridge in the native peptide. 
Paralithocin 1 containing four Nem groups (two reduced Cys-Cys), was observed as its 
[M+5H]5+ ion at m/z 917.1731 (Figure 3c). Its CID spectrum had peaks corresponding to y1+, 
y4+, y5+, y62+, and y82+-y102+, which was due to Cys29-Nem. However, the observation of y374+ # 
- y354+ #, and y353+-y293+, suggest that Cys10 was still disulfide bonded, leaving the remaining 
Cys-Nem at either of Cys14, Cys19, or Cys26 (as no ions indicative of Cys28-Nem were observed). 
The final partial reduced paralithocin 1, containing six Cys-Nem, was observed as its [M+5H]5+ 
ion at m/z 967.5953 (Figure 3d). An ion series of y1+, y4+, y5+, y62+-y102+, and y122+ was observed, 
suggesting Cys28-Nem. Furthermore, the ions y353+-y293+, as well as y273+ and y263+ were 
observed, indicating Cys10-Nem. To summarize, the observed ions indicate Cys6-Cys32 and 
Cys10-Cys28 in native paralithocin 1, but as no ions were observed upon CID of paralithocin 1 




that the triply reduced/alkylated peptide contained an intact Cys14-Cys26 (Cys3-Cys5) disulfide 
bridge. As Cys29-Nem was observed upon CID of the four Cys-Nem containing paralithocin 1, 
it was further deduced that a Cys19-Cys29 (Cys4-Cys7) disulfide existed in the native peptide. 
The fully reduced and alkylated paralithocin 1 ([M+5H]5+ at m/z 1018.0175) produced a 
spectrum where several y-ions were recorded upon CID (Figure 3e). Thus, the coupling pattern 
of disulfide bridges in paralithocin 1 was Cys1-Cys8, Cys2-Cys6, Cys3-Cys5, and Cys4-Cys7. 
 
The native paralithocin 2 ([M+5H]5+ at m/z 1010.0416), produced b1+-b5+ and y62+-y122+ 
ions upon CID, in accordance with intact disulfide bridges at Cys6 and Cys35, respectively. The 
chromatograms of paralithocin 2 with one, two or three reduced and alkylated Cys-Cys bond 
all suggest that minor disulfide scrambling has occurred, as two peaks are observed in each 
chromatogram. Following partial reduction, paralithocin 2 + 2×Nem ([M+5H]5+ at m/z 
1060.4630) produced b2+ to b10+ upon CID, which indicated Cys6-Nem. Singly (y1 to y7) and 
doubly (y8 to y15) charged y-ions were also recorded, which is in accordance with Cys35-Nem 
(Table S4). Hence, in the native paralithocin 2 there was a Cys6-Cys35 (Cys1-Cys8) disulfide 
bridge. The reduction and alkylation of two Cys-Cys in paralithocin 2 gave a compound 
observed as [M+5H]5+ at m/z 1110.8844. Upon CID, b2+ to b10+ ions were recorded, which 
indicated the previously identified Cys6-Nem and an intact disulfide at Cys11 (Cys2), and the 
series y62+ to y162+, which indicated Cys32-Nem (Cys7). The position of the second Cys-Nem 
introduced in this reduction and alkylation step was not identified, but its location at Cys11 and 
Cys31 can be excluded, leaving Cys16, Cys21 and Cys29 as the possible alkylation sites. Next, 
paralithocin 2 with three Cys-Cys bonds reduced and alkylated ([M+5H]5+ at m/z 1161.3082) 
underwent CID. The spectrum contained peaks corresponding to b2+ to b14+ ions, strongly 




Nem, yielding a Cys2-Cys6 in the native peptide. There were no peaks in the spectrum that 
corresponded to reduction and alkylation of any of Cys16 or Cys29, we therefore deduced that 
an intact Cys16-Cys29 (Cys3-Cys5) disulfide bridge remained in triply reduced and alkylated 
paralithocin 2. The disulfide coupling pattern of native peptide was therefore Cys6-Cys35 (Cys1-
Cys8), Cys11-Cys31 (Cys2-Cys6), Cys16-Cys29 (Cys3-Cys5), and Cys21-Cys32 (Cys4-Cys7). A 
large number of ions were recorded upon CID of the fully reduced and alkylated paralithocin 
2, covering almost the entire sequence (Table S4). 
 The final peptide, paralithocin 3, is 51 aa long, has four disulfide bridges, and has the 
same motif as paralithocin 1 and paralithocin 2, that is, CXCCXXC, and it was expected that 
this peptide had the same disulfide bridge coupling pattern as the former peptides. It was, 
however, difficult to record CID spectra of paralithocin 3 with the same quality, that is, a vast 
number of ions indicative of the structure, as was obtained upon CID of paralithocins 1 and 2. 
Native paralithocin 3 ([M+7H]7+ at m/z 795.3528) underwent CID and b2+ to b7+ and y506+ to 
y446+ were observed, indicating Cys8 (Table S5). Ions providing evidence for Cys39 were also 
recorded, that is, y2+ to y10+, y112+, and y122+. The reduction and alkylation of one Cys-Cys in 
paralithocin 3 yielded a [M+7H]7+ ion at m/z 831.3688. Its CID spectrum showed peaks 
indicating Cys8-Nem (Cys1) by the recorded b8+, b102+, y465+ to y374+, and y354+ ions. 
Furthermore, the recorded y2+ to y9+, y112+, y122+, and y142+ ions are indicative of Cys39-Nem, 
suggesting a Cys1-Cys8 bridge in the native peptide. The CID spectra of paralithocin 3 where 
two or more disulfide bridges are reduced and alkylated were hard to interpret, as very few ions 
useful for structure characterization were recorded, most ions were of low abundance (Table 
S5). For (paralithocin 3 + 4×CysNem), the CID spectrum showed peaks corresponding to y10+ 
and y142+ ions, weakly indicating Cys36-Nem (Cys7). A b152+ was also recorded, but this is not 




ions was observed upon CID of (paralithocin 3 + 6×CysNem), that is, y2+-y10+ and y122+-y182+. 
These ions suggest Cys39-Nem, Cys36-Nem, and Cys35-Nem, and if the CXCCXXC motif is 
taken into consideration, this implicates an identical Cys-Cys bridging pattern in paralithocin 3 
as for paralithocin 1 and 2. Unfortunately, no b- or y-ions were observed that could add evidence 
to the anticipated Cys17-Nem, except the y334+ ion, however, this ion had a mass accuracy of 
∆m = – 7.9 ppm.  
 In a peptide having eight cysteines, and where all of them have formed disulfide bridges, 
there are 105 coupling possibilities. The bridging in paralithocins 1 and 2 were identical, both 
having a bond connectivity of Cys1-Cys8, Cys2-Cys6, Cys3-Cys5, and Cys4-Cys7, and there 
is evidence to claim that this also applies to paralithocin 3 (Figure 4). Unwanted disulfide 
scrambling products were not observed during the fragmentation analysis of the paralithocins. 
However, paralithocin 1 was observed almost solely as N-terminal acid during the analysis, 
whereas the amide-carboxylic acid ratio was approximately 8:1 for paralithocin 2 and 2:1 for 
paralithocin 3. As these peptides contain a consensus CXCCXXC motif, it was anticipated an 
identical bridging in all three. Disulfide bridges are found to be remarkably conserved between 
homologous proteins and they are not produced randomly.41 The folding and correct bridge 
formation requires the involvement and aid of several proteins. For an organism to express 
peptides possessing the same motif, it would presumably be more demanding than beneficial 
to have more than one folding and cysteine oxidation apparatus simultaneously running. Cys-
rich AMPs are widely distributed in animals and plants, but although having the same number 
of cysteine residues, the paralithocins show a cysteine arrangement pattern and disulfide 
connectivity different from any known Cys-rich AMPs (Table 1). Disregarding the flanking 
cysteines (Cys1 and Cys8) of the paralithocins, the remaining cysteines fold into a Cys1-Cys5, 




β-defensins and the invertebrate big defensins.42 However, homology searches and sequence 
alignment with selected peptides obtained from these classes reveal no similarities to the 
paralithocins. The paralithocins 1-3 may therefore be assigned to a new family of antimicrobial 
peptides within the group of Cys-rich antimicrobial peptides. 
 
 
Figure 4. Final Cys coupling pattern of paralithocins 1 (P23), 2 (P30), and 3 (P34). 
 
Antibacterial Properties of the Isolated Peptides. The native peptides isolated from 
P. camtschaticus were screened for antibacterial activity against a panel of terrestrial and 
marine bacterial strains. The paralithocins display in general a low to moderate activity against 
microorganisms under the testing conditions used (Table 2).  
 In general, paralithocin 3 was the most potent peptide with minimal inhibitory 
concentration (MIC) values as low as 12.5 µM against C. glutamicum and some Gram-positive 
marine bacterial strains. Paralithocin 1 was the least active peptide with MIC values of 50 µM 
and upwards. This fact might explain why the peptides (especially paralithocin 1) are present 
in relatively high concentrations in the hemocyte extracts. According to the UV-Vis 
chromatogram, the paralithocins are among the major components (with paralithocin 1 being 
the dominant peptide) in the extract. Furthermore, 52.7% of the EST contigs subjected to 
bioinformatics analyses corresponded to the paralithocins, with 40% of them corresponding for 




strains Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli at a 
concentration of 100 µM. Most natural AMPs are considered to kill or inhibit bacteria by 
damaging the outer and/or cytoplasmic membranes. Differences in membrane architecture 
and/or lipid composition might therefore affect the efficacy of AMPs, resulting in varying AMP 
susceptibility of different strains. As a response to low temperatures, marine bacteria optimize 
their membrane fluidity by incorporating long-chain polyunsaturated fatty acids in their 
membranes,43  a membrane composition that might make the marine bacteria more susceptible 
to the paralithocins. Furthermore, due to lower growth rate for marine bacteria at low 
temperatures, a longer incubation period is necessary before any antimicrobial activity can be 
evaluated in vitro. This longer incubation period (72 h at 12 °C versus 24 h at 37 °C), where 
the AMPs are given time to interact with its target(s), might also lead to lower MIC values 
against the marine Gram-positive bacteria. Although the paralithocins display low to moderate 
antibacterial activity in the present study, they might still have an antimicrobial function in vivo. 
The paralithocin producer, the red king crab, is a cold-loving species tolerating water 
temperatures of –1.7 to +11 °C 44 and immature crabs have in laboratory studies shown a 
temperature preference of below 6 °C.45 It remains to be studied whether the paralithocins are 
more potent at temperatures lower than 12 °C. 
 As shown by MS analysis, the ratio for the C-terminal amidated versus C-terminal acid 
forms of paralithocin 1 and 3 was reduced during processing and/or storage. The increased 
proportion of the acid form (with reduced charge) might be responsible for the low activity 
detected for (especially) paralithocin 1. A net positive charge of AMPs is known to facilitate 
electrostatic interactions with the negatively charged membrane and/or cell wall structures of 
bacteria.46  For many other peptides, a C-terminal amide is even required for full biological 




shown for other arthropods.47 SPE extracts from P. camtschaticus hemocytes have previously 
shown to be antibacterial at protein concentrations as low as 31.25 µg/ml, even against E. coli.48 
Assuming that the average molecular weight of the peptides in the extract were around 5 kDa, 
the observed MIC is close to 6 µM, a more than 16-fold lower MIC compared to the most potent 
paralithocin. 
 The reference AMP, cecropin P1, was active against all test bacteria with MIC values 
ranging from 0.8 to 100 µM. In contrast to the disulfide-rich paralithocins, cecropin P1 is a 
linear, α-helical AMP with no disulfide bridges, known to affect bacterial membranes (Kjuul et 
al., 1999). Of note, whereas the paralithocins show increased activity against the marine Gram-
positive bacteria, cecropin P1 display a reduced and moderate activity, indicating different 
mechanism(s) of action between the two types of peptides.  
 Although the antimicrobial activity of the paralithocins are moderate-low, the peptides 
are present (and expressed) in relatively high concentrations indicating they are of importance 
for the animal. As shown for many other AMPs, such molecules may also act as immune 
effectors in vivo.49 AMPs containing eight Cys residues have also shown to have other 
functions. For instance, the insect-derived drosomycin and the structurally related plant 
defensins, all having the cysteine-connectivity of Cys1-Cys8, Cys2-Cys5, Cys3-Cys6, and 
Cys4-Cys7, display multiple biological activities. Although some of them display antibacterial 
activity, their antimicrobial activity is mainly directed against fungi50, 51 and drosomycin also 
display antiparasitic activity.52 In addition, some of the plant defensins inhibit α-amylases53 and 
proteases,54 and some are shown to block calcium,55 potassium,56 and sodium channels.57  
 
Table 2. Antibacterial Activities of the Native Paralithocins and the Reference Peptide Cecropin 




Minimal inhibitory concentrations, MIC (μM)a 
Bacterial 
strainsb 
Gram-negative  Gram-positive  
Terrestrial Marine Terrestrial Marine 
E.c. P.a. Y.r. L.a. A.s. C.g. S.a. C.ma. C.mo. C.d. C.f. 
Paralithocin 1 >100 >100 >100 >100 200 50 >100 200 100 200 200 
Paralithocin 2 >100 >100 n.t.c >100 >100 12.5 >100 50 50 50 25 
Paralithocin 3 >100 >100 100 50 100 12.5 >100 25 12.5 25 12.5 
Cecropin P1 1.6 1.6 0.8 1.6 3.1 1.6 100 50 6.3 25 25 
a MIC was determined as the lowest concentration of peptide causing an optical density less than 50% of the growth 
control. b E.c., Escherichia coli; P.a., Pseudomonas aeruginosa; Y.u., Yersinia ruckeri; L.a., Listonella 
anguillarum; A.s., Aeromonas salmonicida; C.g., Corynebacterium glutamicum; S.a., Staphylococcus aureus; 
C.ma., Carnobacterium maltaromaticum; C.mo., Carnobacterium mobile; C.d., Carnobacterium divergens; C.f., 
Carnobacterium funditum. c n.t., not tested. 
 
In summary, the three paralithocin peptides are the first AMPs isolated from the red 
king crab. The three peptides are all cationic and contain eight cysteines, which are engaged in 
four intramolecular disulfide bridges in the native configuration. Although these peptides only 
possess weak antibacterial activity in vitro, the concentrations at sites of infections in the animal 
might be much higher. In addition, the high redundancy of the EST in the library indicates their 
importance in response to bacterial LPS. Nevertheless, their primary structure and disulfide 
arrangement is unique and could serve as a template for finding other, more potent AMPs in 
other species. Because these peptides seem to be produced in relatively high concentrations in 
vivo, we hypothesize that they play an important role in the animal´s host defense, and have 
other biological functions which remain to be explored. Due to their unique cysteine motifs and 
disulfide arrangement, the paralithocins may be assigned to a previously unknown family of 
AMPs. Further studies should be directed towards studying other biological functions (such as 









 Collection of Animals and Sample Preparation. Live specimens (22 adult animals, 
average weight ca. 1500 g, all males) of the red king crab, Paralithodes camtschaticus,58 were 
collected using crab pots in Varangerfjord, Finnmark, Norway. The animals were kept in tanks 
with circulating seawater until hemolymph collection. Hemolymph was collected from 10 
animals by entering the unsclerotized membrane at the base of the chelipeds and pereiopods, as 
previously described.32 The hemolymph (1925 mL in total) was immediately centrifuged at 800 
x g at 4 °C for 20 min to separate the hemocytes from the plasma. The hemocytes were 
subsequently frozen at –80 °C, lyophilised, pooled and kept frozen at –20 °C until peptide 
extraction and purification. Six animals were used for nucleic acid extractions. 
Lipopolysaccharide (LPS), purified from Aeromonas salmonicida,59 was diluted to a 
concentration of 1 mg/mL in PBS buffer, adjusted to 1000 mOsmol/kg, and injected into four 
animals with a dose of 200 ng/g crab. The injection was done with a G syringe through the 
unsclerotized membrane at the base of the chelipeds and pereiopods. Two control animals were 
treated identically, but injected with only PBS. The hemolymph was collected 42 h after 
injection and the hemocytes were isolated as described above. 
 
 Extraction and Purification of Antimicrobial Peptides. Freeze-dried hemocytes 
(9.92 g) were extracted as previously described.32 Briefly, the material were extracted with 10 




(TFA; Fluka Chemie AG) for 24 h at 4 °C. The supernatant was collected, stored at 4 °C, and 
the residue was extracted once again using the same conditions. The combined supernatants 
were incubated at –20 °C for 1-2 h to allow an organic and an aqueous phase to be partitioned. 
Due to high salt content (from the sample) and high MeCN content, the extraction medium 
precipitates high molecular weight proteins and proteolytic enzymes. The aqueous phase was 
collected, and dried in a vacuum centrifuge (Maxi Dry Lyo, Heto Laboratories). The material 
(3.58 g) was solubilised in 0.05% TFA to a concentration of 100 mg/mL. The extract was 
applied onto a reversed-phase solid phase extraction (SPE) cartridge,32 and the peptides were 
eluted with MeCN-aqueous TFA (0.5%; 40:60, v/v). The peptide containing eluate was dried 
under vacuum, resuspended in 0.05% TFA, and subjected to preparative reversed-phase high 
performance liquid chromatography (RP-HPLC). The HPLC system (Waters Associates) 
consisted of a 600E pump, a 717 autosampler, a 2996 photodiode array (PDA) detector, and a 
SunFire Prep C18 (90Å; 5 µm; 10 x 250 mm) column. Elution was performed with a linear 
gradient running from 0 to 40% MeCN in 0.05% TFA over 75 min, with a flow rate of 2 
mL/min. Absorbance was recorded in the range of 200-400 nm, and peak fractions were 
collected manually. Fractions were dried under vacuum and reconstituted in 200 μL distilled 
H2O, and aliquots (50 μL) of the fractions were tested for antibacterial activity against 
Listonella anguillarum and Corynebacterium glutamicum. Active fractions were analyzed by 
electrospray ionization MS (ESI-MS) to determine their purity. Fractions with impurities were 
subjected to a second round of chromatography on a Symmetry 300 C18 column (Waters; 300 
Å; 5 µm; 4.6 x 250 mm) and eluted under the same experimental conditions as described in step 






 Mass Spectrometry Analysis. Peptide purity was analyzed using a Waters Micromass 
ZQ single quadrupole instrument equipped with an ESI ion source (Micromass Ltd) controlled 
by the MassLynx v4.1 software (Micromass). Samples were dissolved in H2O  and MeOH 
(50:50 v/v) containing 0.02% formic acid. Spectra were recorded in positive ion mode with a 
spray voltage of 3 kV and a cone voltage of 30 V. Samples were infused with a flow rate of 10 
μL/min. Nitrogen was used as desolvation gas (flow 1200 L/h) and cone gas (flow 40 L/h), and 
the ionization temperature was set to 110 °C. The spectra were recorded in the continuum mode 
of acquisition and the quadrupole was scanned from m/z 100 to 2000 at 4 s per scan. MALDI-
TOF analyses of reduced, alkylated and enzyme digested native peptides were done at the 
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, 
United States. The top down MS/MS analysis was combined with the ProSightPTM program 
made by the Kelleher Group of the Department of Chemistry, University of Illinois, USA.60, 61 
 
 Amino Acid Analysis and Sequencing. The HPLC peak fractions P23, P30, and P34 
were dissolved in 6 M HCl and hydrolyzed in vacuum for 20 h at 110 °C. Phenylisothiocyanate 
was added for amino acid derivatization, and phenylthiocarbamyl residues were separated and 
analyzed on an automatic amino acid analyzer (Model 421, Applied Biosystems, Perkin Elmer). 
The instrument was calibrated with 100 pmol of phenylthiohydantoin amino acid standards. 
Edman degradation of native and alkylated (4-vinyl-pyridine) peptides was done at the 
Biotechnology Centre of Oslo (University of Oslo, Norway), and was performed on a protein 
micro sequencer model 477A with a 120A PTH analyzer (Applied Biosystems) and a HP 241 





 Tissue Collection and RNA Extraction. The hemocytes from LPS challenged and non-
challenged king crabs were sampled and subjected to RNA extraction (see below). Briefly, one 
mL of hemolymph was centrifuged at 13.200 rpm for 1 min, the serum was discarded and the 
pelleted hemocytes suspended in 1 ml of Qiazol (Qiagen). To ensure complete lysis, the 
hemocytes were squeezed through a 0.8 mm x 4.0 mm needle and left on ice for 5 min. RNA 
was purified according to the manufacturer’s protocol (Qiagen), and dissolved in 50 mL 1mM 
Na-citrate, pH 6.4 (Ambion). RNA quantity, purity and integrity was verified 
spectrophotometrically (A260/A280) and by 1% agarose gel electrophoresis. The two samples 
containing the highest RNA concentration, were pooled and stored at –80 °C until used. 
 
 cDNA Library Construction and Sequence Analysis. A hemocyte cDNA library from 
LPS-injected animals was constructed with pooled total RNA from hemocytes of two king crabs 
using the SMART cDNA library constructions kit (Clontech) following the manufacturer´s 
instructions for long distance PCR. The cDNA was ligated into the λTriplEx2 arms and 
packaged, using the Gigapack III Gold packaging system (Stratagene). Escherichia coli strain 
BM25.8 was used to convert the λTriplEx2 phage into plasmid pTripleEx2 by mass excision 
and circularization. The converted library with the highest titer (originated from LPS injected 
animals) was then plated and grown overnight at 31 °C on 10 LB agar plates containing 50 
μg/mL carbenicillin each. Three hundred and eighty-four randomly selected clones from this 
library were individually picked (Genetix colony picker robot), cultured in microtiter plates and 
subsequently sequenced from the 5′ end with the Clontech pTriplEx2 forward primer (5′-
AGCTCCGAGATCTGGACGAGC-3′). The library was amplified in B25.8 following the 
manufacturer´s protocol (SMART cDNA library construction kit) and stored with 0.3 % CHCl3  





 Determination of Disulfide Connectivity 
Chemicals and Equipment. Tris(2-carboxyethyl)phosphine hydrochloride (TCEP; 0.5 
M in H2O), citric acid monohydrate, trisodium citrate dihydrate, N-ethylmaleimide (Nem), 
MeOH, and formic acid were purchased from Sigma-Aldrich. Fraction collection (T-piece 9:1 
flow splitting post column) and HRMS/MS was conducted on an Accela 1250 HPLC pump and 
Accela Open autoinjector coupled though an ESI ion source to a QExactive mass spectrometer 
from Thermo, controlled by XCalibur 2.3. The mass spectrometer was operated in full scan 
mode (m/z 750-1250) during semipreparative HPLC, with spray voltage 3 kV, desolvation 
temperature 275 °C, and desolvation gas (nitrogen) at 40 L/h. A Polaris C18A (50 x 2 mm) 
from Agilent reversed-phase HPLC column was used for all separations. The mobile phase 
consisted of A: 0.1% formic acid in H2O, B: MeOH, and a linear gradient 5-30% B over 45 min 
was used to elute the peptides. 
 
Partial Reduction and Alkylation. The peptides, 50 µL of an approximately 50 µg/mL 
solution, were incubated with 10 µL TCEP (1 mM) in 0.25 M citric acid buffer (pH 3.0) at 40 
°C for 5 min, then 10 µL Nem (40 mM in the same buffer) was added and the reaction proceeded 
for 30 min at rt.62 The sample was then immediately subjected to semipreparative HPLC (Vinj: 
25 µL) Fractions were collected manually, and fractions containing peptides with four, three, 
two, one, and zero disulfide bridges were collected. The partial reduction sometimes resulted 
in one major and one or more minor fractions of the partially reduced peptides. In these cases, 
all fractions were collected into separate vials. The most abundant fractions were used for 
further mass spectrometric investigations. The fractions were diluted with MeOH to consist of 





Tandem Mass Spectrometry Experiments. High resolution MS/MS was done by infusing 
the peptide fractions at 5 µL/min. A resolution of 140,000 (@ m/z 200) was used in all 
experiments. For full scan experiments (determination of MW and MI), 30 spectra were 
recorded, and 100-250 spectra were recorded per sample for MS/MS experiments. A 
normalized collision energy (NCE) of 30% was applied in the higher collision dissociation 
(HCD) cell for [M + 5H]5+ precursor ions, NCE = 25% for [M + 6H]6+ and NCE = 20% for [M 
+ 7H]7+. The quadrupole was operated with an isolation width of 4 Th. 
 
Data File Conversion and Data Interpretation. The recorded .raw files were converted 
to mzXML by MassMatrix Mass Spectrometric Data File Conversion Tools 3.9 
(www.massmatrix.org). To interpret all spectra, mMass 4.5.1 was used.63-65 The program was 
slightly rewritten in Python 2.7 (www.python.org) to enable the identification of ions resulting 
from S-S cleavages, that is, [yn +/– H/SH] and [bn +/– H/SH] ions. As the most abundant 
isotopomers all were introduced to the HCD cell, this was exploited in structure 
characterization. The m/z of a monoisotopic ion was calculated by mMass, and during the 
interpretation of the spectra the presence of isotopomers (and the isotope distribution pattern), 
along with the recorded mass accuracy of the monoisotopic ion, was used to determine whether 
a recorded ion was due to an actual dissociation.  
 
Bacterial Strains and Antibacterial Activity Testing. A total of 11 bacterial strains 
were tested for their susceptibility to the isolated peptides. The Gram-positive bacteria C. 
glutamicum (ATCC 13032) and Staphylococcus aureus (ATCC 9144), and the Gram-negative 




in culture at 37 °C. Three marine Gram-negative and fish pathogenic strains, namely L. 
anguillarum (AL104), A. salmonicida (AL2020), and Yersinia ruckeri (CCUG 14190), and five 
marine Gram-positive Carnobacterium strains; C. maltaromaticum (CCUG 34645), C. mobile, 
C. divergens and C. funditum (CCUG 34644) were all grown at 12 °C. All bacteria were grown 
in Mueller Hinton Broth (Difco Laboratories), except the marine Gram-positive Carnobacteria 
strains which were grown in modified Tryptic soy broth with added glucose (5%) and 2% NaCl. 
L. anguillarum and A. salmonicida were provided by the Norwegian Veterinary Institute (Oslo, 
Norway), whereas the marine Gram-positive strains were a gift from Prof. E. Ringø, Norwegian 
College of Fishery Science, UiT The Arctic University of Norway (Tromsø, Norway). 
 The antibacterial activities of the obtained HPLC fractions against two bacterial strains 
(L. anguillarum, and C. glutamicum) were determined as previously described.66 Briefly, 50 μL 
of test material were incubated with an equal volume of actively growing bacteria in 96 well 
Nunc-plates. The starting concentration of bacteria were 5 × 103 cells per well, and the test 
strains were incubated at 37 °C for 24 h, whereas the marine bacteria were incubated at 12 °C 
for 72 h. Bacterial growth was monitored using a Bioscreen C microbiology reader (Labsystems 
Oy). Cecropin P167 (0.5 µg/mL) was used as a positive control for all strains, while distilled 
H2O was added in the growth control. Antibacterial activity was determined when the optical 
density (OD) of the growth control (bacteria plus water) reached an absorbance of 
approximately 0.3. Fractions were regarded as active when the OD was less than 50% of the 
growth control. Serial two-fold dilutions (concentrations ranging from 1.6 to 100 µM) of 
purified, native peptides were made in double distilled H2O and tested for activity against four 
terrestrial and eight marine bacterial strains according to the method described above. For 
selected marine strains, the peptide concentration of P23 was raised to 200 µM. The peptide 




concentration (MIC) was defined as the lowest concentration of peptide causing an OD less 
than 50% of the growth control after 24 and 72 h of incubation for terrestrial and marine 
bacteria, respectively.  
 
Bioinformatics and Sequence Analysis. Sequences were submitted to BLASTX and 
BLASTN68 searches against GenBank provided by the NCBI server 
(www.ncbi.nlm.nih.gov/BLAST). Sequence redundancy was determined by contig analysis 
using CAP369 through the GOCART tool available at www.marinegenomics.org.4 AMP 
similarity searches were performed against APD3, the Antimicrobial Peptide Database 
(aps.unmc.edu/AP/main.html);70  DBAASP, Database of Antimicrobial Activity and Structure 
of Peptides (dbaasp.org/home);71 DRAMP, Data Repository of Antimicrobial Peptides 
(dramp.cpu-bioinfor.org);72 and CAMPR3, Collection of Anti-Microbial Peptides 
(www.camp.bicnirrh.res.in/index.php).73 Isoelectric points was calculated using the Expert 
Protein Analysis System (ExPASy; www.expacy.org) proteomics server of the Swiss Institute 
of Bioinformatics whereas theoretical monoisotopic masses were calculated using the 
ChemCalc online prediction software (http://www.chemcalc.org/).74 Signal peptides was 
predicted by the SignalP 4.1 Server (www.cbs.dtu.dk/services/SignalP).75 Nucleic acid 
sequences were edited and analyzed with the BioEdit program 








This material includes data from amino acid, MS and MS/MS analysis, overview of contigs 
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Table S1. Amino Acid Composition of P23, P30, and P34 
 
Table S1. Amino Acid Composition of P23, P30, and P34, Antimicrobial Peptides 





Composition (mol %) 
 of 
P23 P30 P34 
Aspartic acid/asparaginea 4.0 7.5 8.8 
Threonine 0.0 4.3 2.3 
Serine 22.5 4.3 11.0 
Glutamic acid/glutaminea 7.0 8.1 8.9 
Proline 5.7 21.2 16.1 
Glycine 13.6 11.4 9.1 
Alanine 6.1 12.3 10.7 
Valine 0.0 4.3 2.9 
Cysteineb 18.9 3.8 4.5 
Methionineb 0.0 0.0 0.0 
Isoleucine 8.0 3.1 5.8 
Leucine 0.0 2.9 3.0 
Tyrosineb 1.0 6.1 0.0 
Phenylalanine 0.0 0.0 0.7 
Lysine 3.3 2.7 3.1 
Histidine 0.0 0.6 2.6 
Arginine 9.9 7.4 10.5 
Tryptophanc - - - 
a These amino acids could not be differentiated one from the other. b Partially destroyed 





Table S2. Overview and Redundancy of Contigs obtained from an EST 
Library 
 
Table S2. Overview and Redundancy of Contigs obtained from an EST Library 
originated from Hemocytes of two Red King Crabs 42 h post injection of A. salmonicida 
LPS. Contigs 2, 11 and 16 were selected for further Analysis and are High lightened in 
grey. 
 





of 10 000 EST 
1 3 0,8 80,2 
2 150 40,1 4010,7 
3 4 1,1 107,0 
4 2 0,5 53,5 
5 18 4,8 481,3 
6 2 0,5 53,5 
7 17 4,5 454,5 
8 3 0,8 80,2 
9 3 0,8 80,2 
10 2 0,5 53,5 
11 16 4,3 427,8 
12 3 0,8 80,2 
13 2 0,5 53,5 
14 4 1,1 107,0 
15 2 0,5 53,5 
16 31 8,3 828,9 
Singletons 112 29,9 2994,7 






Table S3. Masses of the Native Paralithocins 
 
Table S3. Masses and calculated Properties of the Native Paralithocins. 
Peptide C-term # aa Monoisotopic mass (Da) Net 
charged Calcd.a Exp.b ∆ mc 































aValues calculated based on cysteines in oxidized forms. bMasses calculated from monoisotopic m/z 
[M+nH]n+ values obtained from ESI-Q-TOF MS spectra. cThe absolute difference between the 
calculated and experimental monoisotopic mass. dNet charge at pH 7 was calculated using 





Table S4. Collision induced dissociation (CID) fragments obtained by 
MS/MS sequencing of native and partially reduced/alkylated 
Paralithocin 2 
 
Table S4. Collision induced dissociation (CID) Fragments obtained by MS/MS 
sequencing of Native and Partially reduced/alkylated Paralithocin 2. (A) Native, intact 
Paralithocin 2, (B) Partially reduced and alkylated with 2 x NEM, (C) Partially reduced 
and alkylated with 4 x NEM, (D) Partially reduced and alkylated with 6 x NEM, (E) 
Completely reduced and alkylated with 8 x NEM. 
 
(A) Paralithocin 2. Native. 4 cystine bridges. [M+5H]5+ @ m/z 1010.0416 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation 
352.7021  352.7012  0.0010   2.7   1.15   2  y6 
381.2132  381.2119  0.0013   3.5   13.92   2  y7 
426.5682  426.5669  0.0013   3.1   3.95   3  y11 
427.2904  427.2888  0.0016   3.8   0.20   1  y3 
438.2474  438.2459  0.0015   3.4   0.80   1  b4 
458.9193  458.9178  0.0015   3.2   11.56   3  y12 
462.7452  462.7436  0.0016   3.5   30.58   2  y8 
526.7929  526.7911  0.0018   3.4   15.66   2  y9 
566.3066  566.3045  0.0021   3.7   28.47   1  b5 
590.8221  590.8203 0.0018   3.1   10.60   2  y10 
639.3488  639.3467  0.0021   3.3   44.22   2  y11 
647.3759  647.3736  0.0023   3.5   0.24   1  y5 
687.8752  687.8731  0.0021   3.1   83.33   2  y12 
704.3973  704.3951  0.0023   3.2   1.72   1  y6 
761.4194  761.4165  0.0029   3.8   14.80   1  y7 
924.4835  924.4799  0.0037   4.0   15.53   1  y8 
1052.5787  1052.5748  0.0039   3.7   2.30   1  y9 
1072.2041  1072.1967  0.0075   6.9   0.13   4  b40 
1277.6921  1277.6862  0.0060   4.7   0.36   1  y11 
1289.5283  1289.5208  0.0075   5.8   0.12   3  b37 
1374.7423  1374.7389  0.0034  2.5   0.59   1  y12 
 
 
(B) Paralithocin 2. 2 x Nem, 3 cystine brigdes. [M+5H]5+ @ m/z 1060.4630 
 
Meas. m/z  Calc. m/z  δ (Da)  δ (ppm)  Rel. Int. (%)  z  Annotation  
174.1355  174.1349  0.0006   3.2   0.08   1  y1  
219.6273  219.6266  0.0007   3.0   1.37   2  b4  
244.1413  244.1404  0.0008   3.4   41.60   1  b2  
271.1886  271.1877  0.0009   3.2   17.91   1  y2 
283.6567  283.6559  0.0008   3.0   1.68   2  b5  
295.6809  295.6797  0.0012   4.0   0.09   2  y4  
341.1943  341.1932  0.0011   3.2   4.34   1  b3  
352.7024  352.7012  0.0012   3.5   0.89   2  y6  
381.2134  381.2119  0.0014   3.8   7.17   2  y7  
397.6857  397.6843  0.0013   3.4   1.53   2  b6  
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426.5684  426.5669  0.0015   3.5  2.80   3  y11  
427.2903  427.2888  0.0015   3.4   0.64   1  y3  
438.2474  438.2459  0.0015   3.4   1.66   1  b4  
458.9194  458.9178  0.0016   3.4   9.38   3  y12  
461.7153  461.7136  0.0017   3.6   0.04   2 b7  
462.7452  462.7436  0.0016   3.4   13.57   2  y8  
526.7929  526.7911  0.0019   3.5   11.29   2  y9  
534.9387  534.9368  0.0019   3.5   0.74   3  y13 
543.2476  543.2453  0.0023   4.2   0.17   2  b8  
566.3067  566.3045  0.0022   3.9   31.44   1  b5  
590.3541  590.3521  0.0022   3.7   0.26   1  y4  
590.8223  590.8203  0.0020   3.4   6.21   2  y10  
639.3490  639.3467  0.0023   3.6   30.56   2  y11  
647.3760  647.3736  0.0024   3.8   0.73   1  y5  
687.8757  687.8731 0.0026   3.7   58.86  2  y12  
704.3977  704.3951  0.0026   3.7   2.38   1  y6  
761.4193  761.4165  0.0027   3.6   12.54   1  y7  
794.3635  794.3614  0.0021   2.7   3.64   1  b6  
801.9043  801.9015  0.0028   3.4   17.43   2  y13  
858.4463  858.4436  0.0027   3.2   22.47   2  y14  
915.9602  915.9570  0.0032   3.5   4.98   2  y15  
922.4229  922.4200 0.0029   3.1   5.89   1  b7  
924.4834  924.4799  0.0035   3.8   13.76   1  y8  
1028.9493  1028.9458  0.0035   3.4   0.06   4  y38  
1052.5789  1052.5748  0.0040   3.8   4.46   1  y9  
1054.2040  1054.2077  -0.0037  -3.5   0.03   4  y39  
1085.4866  1085.4833  0.0033   3.0   0.91   1  b8  
1180.6386  1180.6334  0.0052   4.4   1.26   1  y10  
1186.5263  1186.5310  -0.0047  -4.0   0.31   1  b9  
1277.6915  1277.6862  0.0054   4.2   3.90   1  y11  
1300.5794  1300.5739  0.0055   4.2   0.55   1  b10  
1374.7435  1374.7389  0.0046   3.3  4.16   1  y12  
1715.8849  1715.8799  0.0050   2.9   0.06   1  y14 
 
 
(C) Paralithocin 2. 4 x Nem, 2 cystine brigdes. [M+5H]5+ @ m/z 1110.8844 
 
Meas. m/z Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation  
219.6272  219.6266  0.0006   2.9   1.77   2  b4  
244.1412  244.1404  0.0008   3.2   42.76   1  b2  
271.1885  271.1877  0.0008   3.1   17.88   1  y2  
283.6567  283.6559  0.0008   2.9   2.73   2  b5  
341.1942  341.1932  0.0010   3.0   4.50   1  b3  
352.7022  352.7012  0.0010   2.9   0.05   2  y6  
381.2132  381.2119  0.0013   3.4   7.67   2  y7  
397.6857  397.6843  0.0013   3.4   3.41   2  b6  
438.2476  438.2459  0.0017   3.8   0.98   1  b4  
458.9193  458.9178  0.0015   3.2   2.34   3  y12  
462.7451  462.7436  0.0015   3.2   10.51   2  y8  
526.7927  526.7911  0.0017   3.2   7.56   2  y9  
543.2471  543.2453  0.0018   3.3   0.90   2  b8  
566.3066  566.3045  0.0021   3.6   60.41   1  b5  
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590.8218  590.8203  0.0015   2.5   1.61   2  y10  
593.7713  593.7691  0.0022   3.7   0.26   2  b9  
639.3489  639.3467  0.0022   3.5   18.73   2  y11  
650.7958  650.7906  0.0053   8.1   0.09   2  b10  
687.8754  687.8731  0.0023   3.4   47.31   2  y12  
761.4196  761.4165  0.0030   4.0   8.66   1  y7  
794.3644  794.3614  0.0030   3.8   11.76   1 b6  
801.9045  801.9015  0.0030   3.8   7.37   2  y13  
858.4462  858.4436  0.0027   3.1   16.96   2  y14  
915.9605  915.9570  0.0035   3.8   0.35   2  y15  
922.4226  922.4200  0.0027   2.9   25.51   1  b7  
924.4832  924.4799  0.0034   3.6   8.72   1  y8  
1029.9889  1029.9855  0.0034   3.3   0.34   2  y16  
1052.5785  1052.5748  0.0037   3.5   1.60   1  y9  
1085.4872  1085.4833  0.0039   3.6   4.15   1  b8  
1186.5369  1186.5310  0.0059   5.0   0.48   1  b9  
1277.6880  1277.6862  0.0018   1.4   0.64   1  y11  
1300.5763  1300.5739  0.0024   1.8   1.59   1  b10  
1374.7430  1374.7389  0.0041   3.0   2.52   1  y12  
 
 
(D) Paralithocin 2. 6 x Nem, 1 cystine brigdes. [M+5H]5+ @ m/z 1161.3082 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation  
171.1007  171.1002  0.0005   2.8   0.20   2  b3  
219.6273  219.6266  0.0007   3.0   0.24   2  b4  
244.1412  244.1404  0.0007   3.0   2.51   1  b2  
271.1885  271.1877  0.0008   3.0   0.96   1  y2  
283.6568  283.6559  0.0009   3.1   0.33   2  b5  
295.6806  295.6797  0.0009   2.9   0.00   2  y4  
324.1915  324.1904  0.0011   3.4   0.02   2  y5  
341.1942  341.1932  0.0010   3.0   0.51   1  b3  
352.7023  352.7012  0.0011   3.1   0.07   2  y6  
381.2130  381.2119  0.0011   2.9   0.60   2  y7  
397.6857  397.6843  0.0014   3.5   0.44   2  b6  
426.5685  426.5669  0.0016   3.6   0.05   3  y11  
427.2902  427.2888  0.0014   3.3  0.06   1  y3  
438.2475  438.2459  0.0015   3.5   0.21   1  b4  
458.9194  458.9178  0.0016   3.4   0.16   3  y12  
461.7152  461.7136  0.0016   3.5   0.10   2  b7  
462.7452  462.7436  0.0016   3.5   0.81   2  y8  
526.7929  526.7911  0.0019   3.5   0.56   2  y9  
534.9380  534.9368  0.0012   2.3   0.01   3  y13  
543.2473  543.2453  0.0020   3.6   0.29   2  b8  
566.3066  566.3045  0.0021   3.6   4.45   1  b5  
590.3540  590.3521  0.0019   3.2   0.01   1  y4  
590.8222  590.8203  0.0019   3.2   0.20  2  y10  
593.7712  593.7691  0.0021   3.5   0.20   2  b9  
639.3490  639.3467  0.0023   3.6   0.91   2  y11  
647.3762  647.3736  0.0026   4.0   0.06   1  y5  
650.7927  650.7906  0.0021   3.2   0.02   2  b10  
687.8750  687.8731  0.0019   2.8   2.77   2  y12  
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704.3974  704.3951  0.0023   3.3   0.10   1  y6  
761.4193  761.4165  0.0027   3.6   0.57   1  y7  
764.8217  764.8190  0.0026   3.4   0.33   2  b11  
794.3638  794.3614  0.0025   3.1   1.01   1  b6  
801.9039  801.9015  0.0023   2.9   0.70   2  y13  
835.8585  835.8561  0.0024   2.9   0.05   2  b13  
858.4465  858.4436  0.0029   3.4   1.37   2  y14  
880.7227  880.7211  0.0015   1.7   0.01   3  y21  
915.9606  915.9570  0.0036   3.9   0.15   2  y15  
922.4232  922.4200  0.0032   3.5   1.92   1  b7  
924.4829  924.4799  0.0031   3.3   0.54   1  y8  
980.9217  980.9197  0.0020   2.1   0.00   4  y32  
1029.9890  1029.9855  0.0036   3.4   0.04   2  y16  
1085.4869  1085.4833  0.0037   3.4   0.62   1  b8  
1144.0194  1144.0139  0.0055   4.8   0.00   2  y17  
1172.5284  1172.5246  0.0038   3.2   0.03   2  y18  
1180.6378  1180.6334  0.0044   3.7   0.02   1  y10  
1186.5349  1186.5310  0.0039   3.3   0.30   1  b9  
1277.6907  1277.6862  0.0045   3.5   0.14   1  y11  
1300.5784  1300.5739  0.0045   3.4   0.37   1  b10  
1320.5806  1320.5781  0.0025   1.9   0.02   2  y21  
1374.7440  1374.7389  0.0051   3.7   0.41   1  y12  
1528.6370  1528.6308  0.0062   4.1   0.00   1  b11  
1599.6748  1599.6679  0.0069  4.3   0.01   1  b12  
1602.8013  1602.7958  0.0055   3.4   0.00   1  y13  
1670.7105  1670.7050  0.0055   3.3   0.04   1  b13  
1715.8866  1715.8799  0.0067   3.9   0.25   1  y14  
1769.7773  1769.7734  0.0039   2.2   0.00   1  b14  
1960.8214  1960.8321  -0.0107  -5.4   0.00   2  y32  
 
 
(E) Paralithocin 2. 8 x Nem. [M+5H]5+ @ m/z 1211.7411 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation  
421.2210  421.2194  0.0016   3.8   0.04   3  y11 -NH3  
421.2210  421.2194  0.0016   3.8   0.04   1  b4 -NH3  
426.8958  426.8949  0.0009   2.2   0.04   3  y11  
438.2470  438.2459  0.0010  2.4   2.17   1  b4  
453.1998  453.2003  -0.0006  -1.3  0.26   2  b7 -NH3  
454.2325  454.2303  0.0023   5.0   0.06   2  y8 -H2O  
461.7144  461.7136  0.0008   1.7   2.62   2  b7  
504.2116  504.2116  -0.0000  -0.0   0.18   3  b11 -H2O  
511.2428  511.2397  0.0030   5.9   0.11   4  y16 -H2O  
518.2792  518.2778  0.0015   2.8   1.31   2  y9 -H2O  
534.7344  534.7320 0.0024   4.4  0.66   2  b8 -NH3  
543.2453  543.2453  0.0000   0.0   12.89   2  b8  
566.3046  566.3045  0.0001   0.2   100.00   1  b5  
568.2488  568.2540  -0.0052  -9.1   6.63   4  y17 -H2O  
573.3213  573.3256 -0.0043  -7.5   1.47   1  y4 -H2O  
584.7647  584.7638  0.0009   1.5   3.35   2  b9 -H2O  
593.7694  593.7691  0.0003   0.5  9.63   2  b9  
595.2786  595.2736  0.0050   8.4   0.20   4  b19  
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628.2875  628.2907  -0.0032  -5.1   0.74   3  b15  
630.3470  630.3471  -0.0001  -0.1   4.31   1  y5 -H2O  
630.8339  630.8335  0.0005   0.8   5.98   2  y11 -H2O  
631.3238  631.3255  -0.0017  -2.6   1.28   2  y11 -NH3  
641.7860  641.7853  0.0007   1.1   5.37   2  b10 -H2O  
648.3592  648.3576  0.0016   2.4   0.24   1  y5  
650.7913  650.7906  0.0007   1.0   2.87   2  b10  
687.3691  687.3685  0.0006   0.9   8.17   1  y6 -H2O  
688.0541  688.0499  0.0042   6.1   0.07   4  y21 -H2O  
744.3936  744.3900  0.0036   4.8   42.82   1  y7 -H2O  
755.8141  755.8137  0.0004   0.5   3.76   2  b11 -H2O  
756.3132  756.3057  0.0074   9.8   11.01   2  b11 -NH3  
764.8189  764.8190 -0.0001  -0.1   38.73   2  b11  
777.3334  777.3348  -0.0015  -1.9   0.90   1  b6 -NH3  
791.3333  791.3323  0.0010   1.3   0.03   2 b12 -H2O  
791.8319  791.8243  0.0076   9.6   7.26   2  b12 -NH3  
793.8842  793.8803  0.0039   4.9   2.19   2  y13 -NH3  
794.3673  794.3614  0.0059   7.5   36.40   1  b6  
800.3389  800.3376  0.0013   1.6   15.54   2  b12  
804.8503  804.8503 -0.0000  -0.0   0.14   4  y25  
818.3477  818.3530 -0.0053  -6.5   2.11   4  y26 -NH3  
826.8532  826.8509  0.0024   2.9   1.26   2  b13 -H2O  
827.3449  827.3429  0.0021   2.5   15.28   2  b13 -NH3  
835.8576  835.8561  0.0015   1.8   13.46   2  b13  
849.9321  849.9303  0.0018   2.1   1.87   2  y14 -H2O  
867.3752  867.3805  -0.0052  -6.0   0.06   4  b28 -NH3  
876.8831  876.8771  0.0060   6.8  0.09   2 b14 -NH3  
884.7107  884.7132  -0.0025  -2.8   0.06   3  y20 -H2O  
885.3905  885.3903  0.0002   0.2   1.67  2  b14  
890.7249  890.7167  0.0082   9.2   1.61   3  y20  
904.4077  904.4094  -0.0017  -1.9  0.08   1  b7 -H2O  
905.3963  905.3934 0.0029   3.2   6.63   1  b7 -NH3  
907.4545  907.4533  0.0012   1.3   52.18   1  y8 -H2O  
922.4205  922.4200  0.0006   0.6   72.85   1  b7  
923.7407  923.7358  0.0049   5.3   6.36   3  b21  
925.4683  925.4639  0.0045   4.8   9.89   1  y8  
985.4260  985.4291 -0.0031  -3.2   0.14   3  b23  
1030.4789  1030.4775  0.0014   1.4   5.21   2  y16  
1035.5514  1035.5483  0.0031   3.0   26.21   1  y9 -H2O  
1053.5686  1053.5588  0.0098   9.3   7.34   1  y9  
1085.4873  1085.4833  0.0040   3.7   42.32   1  b8  
1110.4989  1110.4882  0.0107   9.6   0.06   4  y35 -H2O  
1135.5178  1135.5006  0.0172   15.1   0.06   2  y17 -H2O  
1144.5046  1144.5059  -0.0013  -1.1   8.39   2  y17  
1163.6060  1163.6069 -0.0009  -0.8   8.01   1  y10 -H2O  
1164.0214  1164.0114  0.0100   8.6   0.19   2  y18 -H2O  
1168.5203  1168.5204  -0.0001  -0.1   10.35   1  b9 -H2O  
1173.0278  1173.0166  0.0112   9.5   15.29   2  y18  
1186.5319  1186.5310  0.0009   0.8   25.58   1  b9  
1260.6680  1260.6596  0.0084   6.6   31.09   1  y11 -H2O  
1278.0499  1278.0398  0.0101   7.9   0.17   2  y19 -H2O  
1279.0353  1279.0392  -0.0039  -3.1   0.48   4  b39 -H2O  
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1283.5565  1283.5523  0.0042   3.3   7.28   3  y30  
1283.5565  1283.5474  0.0092   7.1   7.28   1  b10 -NH3  
1300.5770  1300.5739 0.0031   2.4   37.07   1  b10  
1326.5774  1326.5662  0.0112   8.5   8.19   2  y20 -H2O  
1335.5758  1335.5715  0.0044   3.3   28.14   2  y20  
1357.7184  1357.7124  0.0060   4.4   95.16   1  y12 -H2O  
1367.0819  1367.0738  0.0082   6.0   0.33   4  b43  
1375.0896  1375.0926  -0.0030  -2.1   19.08   2  y21 -H2O  
1375.7140  1375.7229  -0.0090  -6.5   31.63   1  y12  
1376.0977  1376.0948  0.0029   2.1   26.16  2  b21 -H2O  
1384.1110  1384.0978  0.0131   9.5   53.98   2  y21  
1385.1094  1385.1000  0.0093   6.7   37.30   2  b21  
1425.6257  1425.6164  0.0093   6.6   0.09   2  y22 -H2O  
1426.1162  1426.1084  0.0078   5.5   0.40   2  y22 -NH3  
1429.6122  1429.6168  -0.0047  -3.3   0.11   3  y33  
1429.6122  1429.6095  0.0027   1.9   0.11   4  y44  
1434.6309  1434.6217  0.0092   6.4   11.36   2  y22  
1507.6509  1507.6401  0.0108   7.2   0.27   2  y23 -NH3  
1516.1659  1516.1533  0.0126   8.3   8.59   2  y23  
1528.6432  1528.6308  0.0124   8.1   4.06   1  b11  
1551.6848  1551.6719  0.0129   8.3   5.91  2  y24 
1585.7723  1585.7692  0.0031   2.0   32.45   1  y13 -H2O  
1599.6768  1599.6881  -0.0113  -7.1   7.53   2  y25 -H2O  
1599.6768  1599.6679  0.0089   5.6   7.53   1  b12  
1603.7935  1603.7798  0.0137   8.5   9.47   1  y13  
1608.7046  1608.6934  0.0112   7.0   3.46   2  y25  
1644.2090  1644.2119  -0.0029  -1.8   2.31   2  y26  
1645.2081  1645.2141 -0.0060  -3.6   1.59   2  b26  
1653.6863  1653.6784  0.0078   4.7   1.32   1  b13 -NH3  
1670.7111  1670.7050 0.0061   3.6   21.38   1  b13  
1698.8556  1698.8533  0.0023   1.3   28.23   1  y14 -H2O  
1752.7544  1752.7469  0.0075   4.3   0.11   1  b14 -NH3  
1758.2520  1758.2404  0.0116   6.6   4.37   2  y27  
1769.7780  1769.7734 0.0046   2.6   7.68   1  b14  
1813.8782  1813.8803  -0.0021  -1.1   3.76   1  y15 -H2O  
1814.8768  1814.8643  0.0126   6.9   3.69   1  y15 -NH3  
1882.8635  1882.8575  0.0061   3.2   5.29   1  b15  
1973.3547  1973.3512  0.0036   1.8   0.97   2 y31  
2042.9064  2042.9211  -0.0148  -7.2   0.28   1  y16 -NH3  
2326.9951  2327.0154  -0.0203  -8.7   0.37   1  y18 -H2O  
2328.0144  2327.9995  0.0150   6.4   0.51   1  y18 -NH3  
2556.0708  2556.0563  0.0145   5.7   0.16   1  y19 -NH3  
2652.1387  2652.1251  0.0136   5.1   1.30   1  y20 -H2O  
2653.1245  2653.1091  0.0154   5.8   3.97   1  y20 -NH3  
2749.1677  2749.1778  -0.0101  -3.7   2.77   1  y21 -H2O  
2750.1609  2750.1618 -0.0010  -0.3   7.94   1  y21 -NH3  
2751.1641  2751.1823  -0.0182  -6.6   7.32   1  b21 -H2O  




Table S5. Collision induced dissociation (CID) fragments obtained by 
MS/MS sequencing of Native and partially alkylated Paralithocin 3 
 
Table S5. Collision induced dissociation (CID) fragments obtained by MS/MS 
sequencing of Native and partially alkylated Paralithocin 3. (A) Native, intact 
paralithocin 3, (B) Partially Reduced and alkylated with 2 x NEM, (C) Partially reduced 
and alkylated with 4 x NEM, (D) Partially reduced and alkylated with 6 x NEM, (E) 
Completely reduced and alkylated with 8 x NEM. 
 
(A) Paralithocin 3. Native. 4 cystine brigdes. [M+7H]7+ @ m/z 795.3528 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation  
244.1404  244.1404  0.0000   0.0   33.89   1  b2  
253.1296  253.1295  0.0001   0.4   0.14   1  y2  
291.6350  291.6352  -0.0002  -0.7   0.00   2  y6  
367.1731  367.1724  0.0006   1.7   0.54   1  y3  
372.1994  372.1990  0.0004   1.0   100.00   1  b3  
454.2051  454.2045  0.0006   1.3   1.78   1  y4  
469.2523  469.2518  0.0005   1.1   0.23   1  b4  
503.2255  503.2249  0.0006   1.2   0.03   2  y9  
525.2424  525.2416  0.0009   1.6   0.49   1  y5  
526.2737  526.2732  0.0005   1.0   3.84   1  b5  
559.7674  559.7669  0.0005   0.9   0.00   2  y10  
582.2642  582.2631  0.0011   1.9   0.92   1  y6  
623.3262  623.3260  0.0002   0.3   0.05   1  b6  
724.3743  724.3737  0.0007   0.9   0.06   1  b7  
745.3275  745.3264  0.0011   1.5   0.20   1  y7  
807.1765  807.1809  -0.0044  -5.5   0.00   6  y44  
824.0258  824.0222  0.0037   4.5   0.01   6  y45  
840.2001  840.1976  0.0025   3.0   0.13   6  y46 
849.7040  849.7012  0.0028   3.3   0.01   6  y47  
865.8793  865.8767  0.0026   3.0   0.29   6  y48  
887.2219  887.2198  0.0021   2.4   0.02   6  y49  
901.7289  901.7251  0.0039   4.3   0.10   6  y50  
968.4193  968.4156  0.0037   3.8   0.21   5  y44  
988.6295  988.6251  0.0044   4.4   1.03   5  y45  
1008.0393  1008.0357  0.0036   3.5   3.52   5  y46  
1019.4434  1019.4400  0.0035   3.4   1.31   5  y47  
1038.8538  1038.8505  0.0032   3.1   0.86   5  y48  
1064.4596  1064.4622  -0.0026  -2.5   0.20   5  y49  
1081.8683  1081.8687  -0.0003  -0.3   0.00   5  y50  
1210.2623  1210.2677  -0.0053  -4.4   0.18   4  y44  
1235.5309  1235.5296  0.0013   1.0   1.67   4  y45  
1259.7921  1259.7928  -0.0007  -0.5   0.35   4  y46  











(B) Paralithocin 3. Native 2 x Nem, 3 cystine brigdes. [M+7H]7+ @ m/z 831.3688 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%) z  Annotation 
252.1462  252.1455  0.0007   2.6   3.79   1  y2  
366.1894  366.1884  0.0010   2.7   2.45   1  y3  
453.2217  453.2205  0.0013   2.8   10.48   1  y4  
524.2593  524.2576  0.0018   3.4   4.04   1  y5  
581.2808  581.2790  0.0018   3.1   9.16   1  y6  
623.3289  623.3260  0.0029   4.6   0.07   1  b6  
637.3276  637.3255  0.0021   3.3   0.06   2  y11  
724.3757  724.3737  0.0021   2.9   6.26   1  b7  
744.3446  744.3424  0.0022   3.0   1.53   1  y7  
873.3792  873.3809  -0.0016  -1.9   0.05   5  y38  
895.3891  895.3905  -0.0014  -1.5   0.06   5  y39 -H2O   
907.4108  907.4057  0.0051   5.7   0.89   1  y8  
915.4001  915.4009  -0.0009  -0.9   0.16   5  y40 -NH3 
936.2140  936.2127  0.0013   1.4   0.14   5  y41  
953.6178  953.6191  -0.0013  -1.3   0.14   5  y42  
973.0302 973.0296  0.0005   0.6   0.66   5  y43   
991.6641  991.6726  -0.0085  -8.5   0.02   4  y34   
1004.4619  1004.4585  0.0035   3.4   0.66   1  y9  
1012.9246  1012.9163  0.0083   8.2   0.06   4  y35 -NH3  
1018.6485  1018.6410  0.0075   7.4   0.05   5  y44  
1038.8565  1038.8505  0.0059   5.7   1.28   5  y45   
1040.9324  1040.9413  -0.0089  -8.6   0.04   4  y36 -H2O  
1040.9489  1040.9413  0.0075   7.2   0.03   4  y36 -H2O 
1041.1919  1041.1873  0.0046   4.4   0.10   4  y36 -NH3  
1054.6627  1054.6590  0.0038   3.6   1.30   5  y46 -H2O   
1054.8629  1054.8558  0.0072   6.8   0.84   5  y46 -NH3  
1058.2634  1058.2611  0.0024   2.2   0.41   5  y46   
1066.0648  1066.0633  0.0016   1.5   0.07   5  y47 -H2O  
1066.2626  1066.2601  0.0025   2.4   0.03   5  y47 -NH3  
1069.6692  1069.6654  0.0038   3.6   0.15   5  y47 
1073.7122  1073.7150  -0.0028  -2.6   0.12   4  y37   
1086.9716  1086.9716  -0.0001  -0.0   0.23   4  y38 -H2O  
1087.2208  1087.2176  0.0032   3.0   0.35   4  y38 -NH3  
1089.0775  1089.0759  0.0016   1.5   0.17   5  y48  
1091.4764  1091.4743 0.0022   2.0   0.24   4  y38   
1114.6854  1114.6876  -0.0022  -2.0   0.77   5  y49  
1118.9945  1118.9863  0.0083   7.4   0.28   4  y39 -H2O   
1119.2328  1119.2323  0.0005   0.5   0.23   4  y39 -NH3  
1123.4876  1123.4889  -0.0013  -1.2   0.34   4  y39  
1128.4807  1128.4919  -0.0112  -9.9   0.20   5  y50 -H2O  
1148.2504  1148.2560  -0.0056  -4.9   0.64   4  y40   
1165.7555  1165.7574  -0.0019  -1.6  0.24   4  y41 -NH3  
1170.0042  1170.0140  -0.0099  -8.4   0.34   4  y41   
1187.2623  1187.2694  -0.0070  -5.9   0.17   4  y42 -H2O  
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1187.5159  1187.5154  0.0005   0.4   0.62   4  y42 -NH3  
1191.7651  1191.7720  -0.0069  -5.8   0.36   4  y42  
1216.0248  1216.0352  -0.0104  -8.6   0.09   4  y43  
1268.5492  1268.5468  0.0024   1.9   0.55   4  y44 -H2O  
1268.7992  1268.7928  0.0064   5.1   0.51   4  y44 -NH3  
1273.0386  1273.0494  -0.0108  -8.5   0.83   4  y44  
1293.8019  1293.8087  -0.0068  -5.3   0.13   4  y45 -H2O  
1294.0581  1294.0547  0.0034   2.6   0.44   4  y45 -NH3  
1298.3079  1298.3113  -0.0035  -2.7   0.57   4  y45  
1318.0647  1318.0719  -0.0072  -5.5   0.15   4  y46 -H2O 
1318.3242  1318.3179  0.0063   4.8   0.05   4  y46 -NH3  
1322.5747  1322.5745  0.0002   0.1   0.26   4  y46  
1332.5729  1332.5733  -0.0004  -0.3   0.06   4  y47 -NH3  
1349.9044  1349.8913  0.0131   9.7   0.03   3  y35 -H2O  
1388.5953  1388.6051  -0.0098  -7.0   0.03   4  y49 -H2O  
1410.5984  1410.6091  -0.0107  -7.6   0.25   4  y50 -NH3  
1448.9473  1448.9597  -0.0125  -8.6   0.22   3  y38 -H2O  
1449.2797  1449.2877  -0.0081  -5.6   0.08   3  y38 -NH3 
1454.9528  1454.9632  -0.0105  -7.2   0.15   3  y38  
1491.6421  1491.6459  -0.0038  -2.6   0.26   3  y39 -H2O  
1491.9761  1491.9739  0.0022   1.4   0.35   3  y39 -NH3  
1497.6445  1497.6494  -0.0049  -3.3   0.33   3  y39  
1524.6593  1524.6687  -0.0094  -6.2   0.67   3  y40 -H2O  
1524.9911  1524.9967  -0.0056  -3.7   0.67   3  y40 -NH3  
1530.6560  1530.6722  -0.0162  -10.6   0.07   3  y40  
1553.6655  1553.6794  -0.0139  -8.9   0.04   3  y41 -H2O  
1559.6643  1559.6829  -0.0186  -11.9   0.13   3  y41  
1583.0164  1583.0181  -0.0017  -1.1   0.04   3  y42 -NH3  
1615.3523  1615.3690  -0.0167  -10.3   0.63   3  y43 -NH3  
1621.0283  1621.0445  -0.0162  -10.0   0.12   3  y43  
1691.0415  1691.0599  -0.0184  -10.9   0.04   3  y44 -H2O  
1691.3829  1691.3880  -0.0050  -3.0   0.03   3  y44 -NH3  
 
 
(C) Paralithocin 3. Native 4 x Nem, 2 cystine brigdes. [M+7H]7+ @ m/z 867.3836 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation 
244.1411  244.1404  0.0007   2.8   3.38   1  b2  
252.1463  252.1455  0.0006   2.5   0.12   1  y2  
291.1435  291.1432  0.0004   1.3   0.06   2  y6  
366.1895  366.1884  0.0011   3.0   0.06   1  y3  
453.2218  453.2205  0.0014   3.0   0.85   1  y4  
524.2590  524.2576  0.0014   2.7   0.11   1  y5  
581.2806  581.2790  0.0016   2.8   1.61   1  y6  
817.3525  817.3542  -0.0018  -2.1   0.12   5 y33 -H2O  
836.8597  836.8689  -0.0093  -11.1   0.08   6  y42  
843.9658  843.9617  0.0040   4.8   0.07   5  y34  
864.3596  864.3621  -0.0025  -2.8   0.05   5  y35  
872.4246  872.4228  0.0017   2.0   0.13   2  y14  
923.8069  923.8031  0.0038   4.1   0.10   5  y38  
932.9103  932.9073  0.0030   3.2   0.06   4  y30  
969.2258  969.2285  -0.0026  -2.7   0.17   5  y40  
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986.6293  986.6349  -0.0055  -5.6   0.17   5  y41  
997.4394  997.4329  0.0065   6.5   0.10   4  y32  
1004.0408  1004.0413  -0.0005  -0.5   0.56   5  y42 
1023.4531  1023.4518  0.0013   1.2   2.27   5  y43  
1025.9440  1025.9436  0.0004   0.3   0.05   4  y33  
1069.0602  1069.0632  -0.0030  -2.8   0.18   5  y44  
1089.2671  1089.2727  -0.0056  -5.2   0.13   5  y45  
1108.4686  1108.4717  -0.0031  -2.8   0.12   4  y36  
1108.6882  1108.6833  0.0050   4.5   0.31   5  y46  
1116.6857  1116.6823  0.0034   3.1   0.29   5  y47 -NH3  
1117.5442  1117.5425  0.0017   1.5   0.06   1  y10  
1136.7422  1136.7427  -0.0005  -0.5   0.07   4  y37  
1139.5096  1139.4981  0.0115   10.1   0.08   5  y48  
1154.5021  1154.5020  0.0001   0.1   0.35   4  y38  
1165.1079  1165.1098  -0.0019  -1.7   0.29   5  y49  
1182.0232  1182.0140  0.0092   7.8   0.08   4  y39 -H2O  
1182.5153  1182.5163  -0.0010  -0.8   0.27   5  y50  
1243.5349  1243.5406  -0.0057  -4.6   0.10   3  y30   
1250.5458  1250.5431  0.0027   2.1   0.45   4  y42 -NH3  
1274.7946  1274.8063  -0.0118  -9.2   0.87   4  y43 -NH3  
1329.5679  1329.5748  -0.0069  -5.2   0.40   3  y32  
1336.0717  1336.0772  -0.0055  -4.1   0.16   4  y44  
1361.3304  1361.3391  -0.0086  -6.3   0.05   4  y45  
1533.3361  1533.3247  0.0113   7.4   0.07   3  y38 -NH3  
 
 
(D) Paralithocin 3. Native 6 x Nem, 1 cystine brigdes. [M+7H]7+ @ m/z 903.4006 
 
Meas. m/z  Calc. m/z  δ (Da)   δ (ppm)  Rel. Int. (%)  z  Annotation  
252.1462  252.1455  0.0007   2.7   3.36   1  y2  
366.1892  366.1884  0.0008   2.2   0.53   1  y3  
453.2218  453.2205  0.0013   2.9   8.70   1  y4  
524.2592  524.2576  0.0017   3.1   3.13   1  y5  
581.2807  581.2790  0.0017   2.9   7.52   1  y6  
694.3500  694.3469  0.0031   4.4   0.20   2  y12  
744.3445  744.3424  0.0022   2.9   2.93   1  y7  
781.3436  781.3470  -0.0033  -4.3   0.16   3  y18  
808.3781  808.3754  0.0027   3.3   1.53   2  y13  
872.4262  872.4228  0.0034   3.9   3.20   2  y14  
907.4108  907.4057  0.0051   5.7   0.35   1  y8  
907.9435  907.9414  0.0022   2.4   0.36   2  y15  
914.7839  914.7842  -0.0003  -0.3   0.16   5  y35  
937.3944  937.4010  -0.0067  -7.1   0.14   5  y36  
960.0270  960.0178  0.0091   9.5   0.17   5  y37  
974.2256  974.2253  0.0003   0.3   0.33   5  y38  
999.8365  999.8370  -0.0005  -0.5  0.56   5  y39  
1004.4616  1004.4585  0.0031   3.1   0.89   1  y9  
1019.6416  1019.6507  -0.0091  -8.9   0.65   5  y40  
1028.9529  1028.9468  0.0061   6.0   0.22   4  y32  
1054.4618  1054.4635  -0.0017  -1.6   0.84   5  y42  
1057.4611  1057.4575  0.0036   3.4   0.63   4  y33  
1073.8770  1073.8740  0.0029   2.7   0.65   5  y43  
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1117.5435  1117.5425  0.0009   0.8   0.18   1  y10  
1119.4868  1119.4854  0.0014   1.3   1.16   5  y44  
1139.6845  1139.6949  -0.0105  -9.2   0.22   5  y45  
1143.2332  1143.2284  0.0047   4.1   0.20   4  y35  
1159.1096  1159.1055  0.0041   3.6   0.54   5  y46  
1170.4981  1170.5098  -0.0117  -10.0   0.18   5  y47  
1171.4967  1171.4995  -0.0028  -2.3   0.46   4  y36  
1171.5087  1171.5168  -0.0081  -6.9   1.11   2  y18   
1171.5087  1171.4995  0.0092   7.9   1.11   4  y36  
1189.9171  1189.9203  -0.0032  -2.7  0.19   5  y48  
1214.5282  1214.5182  0.0100   8.2   0.17   3  y28  
1215.5332  1215.5320  0.0012   1.0   13.22   5  y49 
1217.5265  1217.5298  -0.0033  -2.7   0.28   4  y38  
1249.5415  1249.5444  -0.0029  -2.3   1.10   4  y39  
1266.5474  1266.5519  -0.0046  -3.6   1.79   3  y29  
1274.3113  1274.3115  -0.0002  -0.2   0.37   4  y40  
1285.5657  1285.5591  0.0066   5.1   0.20   3  y30  
1296.0689  1296.0695  -0.0007  -0.5   0.25   4  y41  
1317.8182  1317.8275  -0.0093  -7.0   0.38   4  y42  
1319.5518  1319.5596  -0.0078  -5.9   0.21   3  y31  
1365.0852  1365.0893  -0.0041  -3.0   1.29   2  y21  
1371.5885  1371.5933  -0.0048  -3.5   0.48   3  y32  
1371.5890  1371.5933  -0.0043  -3.1   1.46   3  y32  
1399.0994  1399.1049  -0.0056  -4.0   0.26   4  y44  
1409.6051  1409.6076  -0.0025  -1.7   0.54   3  y33  
1424.3574  1424.3668  -0.0094  -6.6   0.25   4  y45  
1599.3710  1599.3582  0.0128   8.0   0.21   3  y37  
1623.0260  1623.0372  -0.0112  -6.9   0.20   3  y38  
1665.7230  1665.7234  -0.0004  -0.2   0.29   3  y39  
 
 
(E) Paralithocin 3. Native 4 x Nem. [M+7H]7+ @ m/z 939.4169 
 
Meas. m/z Calc. m/z δ (Da)  δ (ppm) Rel. Int. (%) z Annotation 
116.071 116.071  0.001   4.3   2.03   1  y1 
253.130  253.130  0.001   2.2   0.15   1  y2 
367.173  367.172  0.001   2.4   0.16   1  y3 
454.209  454.204  0.005   10.1   0.73   1  y4 
525.245  525.242  0.003   6.4   0.21   1  y5  
551.254  551.254  0.000   0.6   0.01   2  y10 -NH3   
582.265  582.263  0.002   2.6   0.40   1  y6 
582.284  582.279  0.005   8.8   0.53   3  y14  
639.262  639.266  -0.004   -6.2   0.00   4  y19 -NH3  
678.293  678.291  0.002   3.5   0.01   4  y20 -NH3  
745.328  745.326  0.002   2.5   0.12   1  y7  
893.390  893.381  0.009   10.0   0.02   5  y33 -NH3  
908.393  908.390  0.003   3.4   0.07   1  y8   
908.442  908.433  0.009   9.8   0.04   2  y15  
916.388  916.387  0.001   1.5   0.01   5  y34 -NH3   
921.136  921.142  -0.006   -6.8   0.01   4  y27   
947.074  947.066  0.008   8.5   0.01   3  y21 -NH3  
972.407  972.417  -0.010   -10.5   0.01   6  y44 -NH3   
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981.930  981.926  0.004   4.4   0.03   4  y29   
991.931  991.924  0.007   6.6   0.02   4  y30 -NH3   
1005.443  1005.442  0.001   0.6   0.03   1  y9   
1005.443  1005.434  0.009   9.2   0.03   6  y46 -NH3   
1013.957  1013.949  0.008   7.9   0.01   2  y16 -NH3   
1014.932  1014.937  -0.005   -5.0   0.03   6  y47 -NH3  
1017.768  1017.775  -0.007   -7.1   0.02   6  y47  
1024.851  1024.844  0.007   6.6   0.01   5  y38   
1033.943  1033.951  -0.007   -6.9   0.04   6  y48   
1050.466  1050.456  0.010   9.7   0.01   5  y39   
1052.464  1052.456  0.008   7.7   0.02   6  y49 -NH3 
1066.961  1066.961  -0.000   -0.0   0.02   6  y50 -NH3  
1069.807  1069.799  0.008   7.9   0.01   6  y50  
1070.265  1070.270  -0.005   -4.2   0.01   5  y40  
1087.679  1087.676  0.003   3.0   0.01   5  y41  
1105.081  1105.082  -0.002   -1.6   0.02   5  y42  
1120.740  1120.731  0.008   7.5   0.06   4  y33  
1122.483  1122.481  0.002   2.2   0.11   3  y25 -NH3  
1124.493  1124.493  0.000   0.3   0.04   5  y43  
1127.987  1127.977  0.010   8.6   0.03   2  y17 -NH3  
1136.492  1136.490  0.002   1.4   0.02   2  y17  
1149.477  1149.488  -0.011   -9.9   0.01   4  y34  
1163.502  1163.496  0.007   5.9   0.04   2  y18 -NH3  
1172.010  1172.009  0.001   1.2   0.04   2 y18  
1190.323  1190.314  0.009   7.5   0.02   5  y45  
1204.183  1204.175  0.008   6.9   0.01   3  y26  
1206.330  1206.319  0.011   8.7   0.01   5  y46 -NH3  
1217.734  1217.723  0.011   9.1   0.01   5  y47 -NH3  
1221.138  1221.129  0.009   7.7   0.01   5  y47  
1222.188  1222.179  0.009   7.7   0.01   3  y27 -NH3  
1227.854  1227.854  -0.000   -0.2   0.01   3  y27  
1234.783  1234.773  0.010   7.8   0.03   4  y36  
1240.545  1240.539  0.006   4.6   0.13   5  y48  
1263.054  1263.044  0.010   7.8   0.09   4  y37  
1266.154  1266.151  0.003   2.4   0.05   5  y49  
1280.803  1280.804  -0.001   -0.7   0.05   4  y38  
1283.566  1283.557  0.008   6.3   0.10   5  y50  
1303.228  1303.223  0.005   3.7   0.02   3  y29 -NH3  
1312.824  1312.818  0.006   4.4   0.04   4  y39  
1322.229  1322.230  -0.001   -0.6   0.03   3  y30 -NH3  
1327.897  1327.906  -0.008   -6.1   0.02   3  y30  
1337.575  1337.585  -0.010   -7.3  0.04   4  y40  
1359.340  1359.343  -0.004   -2.7   0.01   4  y41  
1364.091  1364.088  0.004   2.7   0.01   2  y20  
1381.102  1381.101  0.001   0.7   0.01   4  y42  
1398.259  1398.249  0.010   7.0   0.02   3  y31 -NH3  
1401.106  1401.108  -0.002   -1.2   0.02   4  y43 -NH3  
1428.595  1428.609  -0.014   -9.5   0.01   2  y21 [31-51]  
1450.283  1450.283  0.000   0.3   0.03   3  y32 -NH3  
1455.953  1455.958  -0.005   -3.6   0.07   3  y32  
1476.636  1476.638  -0.001   -0.9   0.03   2  y22 -NH3  
1488.308  1488.297  0.011   7.3   0.03   3  y33 -NH3  
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1493.985  1493.973  0.013   8.5   0.01   3  y33  
Figure S1. Consensus nucleotide and amino acid sequences of contigs 
 
(A)  Contig 2 - Paralithocin 1 
1   CATCAGTAAGAAAGAATCCAGTCGGGACTCAGGACAGAACTCAGCTACTATTTCCACTCT 60   
 
61  TACAGGTTGTGTTGACAGTTAACCATGGGTCCCATGAAGGTGTTGTTGGTTCTGTTGGTG 120  
                             M  G  P  M  K  V  L  L  V  L  L  V  
 
121 GTCATGGTGGCTGCACCACACATTGCAGATGCTTGGCAGCAACCGTCCTGTAGTTCCATC 180  
     V  M  V  A  A  P  H  I  A  D  A  W  Q  Q  P  S  C  S  S  I  
 
181 TGCGACTATAGCTGCGGCAAATCCGCCTGTATCTCCTACAGTGGTAGATGCGGCTGTTGC 240  
     C  D  Y  S  C  G  K  S  A  C  I  S  Y  S  G  R  C  G  C  C  
 
241 GCTTCCTGCCGCAGAGGACCGATTTACGGTTGACGCTGAAGGAGGAGGATCCACCCCCAG 300  
     A  S  C  R  R  G  P  I  Y  G  * 
 
301 GAGAACCCCCAGGAGAACTGACCCACTCACTATACACCGTTCACATTAGCTTGTGCTTTA 360  
361 ATGTACCCCTTTGCTTACGAGCAACCTTTTTCTGAGCTTGAGATAAAATCGTCTAATGTT 420  
421 AGCCATTGAACAAATCAATCGTGGCTGCATAACAGGGTCAGTATCTCTGACGTTCATTAT 480  
481 GAAGCATATCCATTTGTATTTTTGAAGTCCCTTTAAGCAGTATTATATAAGATATATCAT 540  
541 GATATAGAATACCCCTGTAGTCTAACGTCTATTTACTTTATCATGTGCTTTAATAAAACT 600  
601 TATCATGTACGGTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 644  
 
 
(B)  Contig 16 - Paralithocin 2 
1   GACACCAGTAAGAAAGAATCCAGTTGGGAGTCAGGACAGAGCTCTCTGGAACTTCCACTC 60   
 
61  TTACAGATTGTGTTGATATTTGAACCATGGGAGCCGCGAAGGTGTTGTTGGTTGTGTTGG 120  
                               M  G  A  A  K  V  L  L  V  V  L  
 
121 CGGTCATGGTGGCTGTACCTAACCTTGCAGAGGGTAGGTCTCCACCACAATGCCAATATA 180  
    A  V  M  V  A  V  P  N  L  A  E  G  R  S  P  P  Q  C  Q  Y  
 
181 CTAACTGCGCTGCTGTGTTATGTCCAGCCGTCTACTGTGCAAACGCCTACACACCCCCGT 240  
    T  N  C  A  A  V  L  C  P  A  V  Y  C  A  N  A  Y  T  P  P  
 
241 GTGGCTGCTGTGACATCTGCCCTCCACAGAAATACGGAGGTGGCTACCGGCCTAGAGGCT 300  
    C  G  C  C  D  I  C  P  P  Q  K  Y  G  G  G  Y  R  P  R  G  
 
301 GAAGGAGGAGGACCCACCCCCAGGMGAACCCCCAGGAGAACTGACCCATTCACTATACAC 360  
    *   
361 CGTACACATTAACTGGACAAATTTACTTCTCCTAGCAGTTAGTTATAATTAGCTGAAACT 420  
421 GTATTAATCTATTCACATATTGCTGCTAGCCAATCACATTCATTCGTAGCTGCTCGCCAG 480  
481 GATAAAATCGACACCTAAATGGCACGAAAGGTCTTAAAATTGACAGAATGGGGCGGAAAT 540  
541 TCTTATGCTTATTATTATTAAAATATAATAATCTTATACCTAAAGGTTTGGAATGATTCA 600  
601 ACGGTTAATAATGAACTTGGACTTTATTCAATAAACCCTTCTGATCTGAGTACTKHRAAA 660  





(C)  Contig 11 - Paralithocin 3 
1   GAGTTCAGTGAAGAGCAAATCAGGACGAGATACACTGTTGCTTTAATTTTCAAGGTTGCG 60    
 
61  TTGTGTGGTCAGTTAACCATGGGTCCCATGAAGGTGTTGTTGGTTATGTTGGTGGTCATG 120   
                        M  G  P  M  K  V  L  L  V  M  L  V  V  M  
 
121 GTGGCTGCTCCCCACATCGCAGATGCTAGGAGTCAACCAGGACCAACCTGTCCATCCTCT 180   
      V  A  A  P  H  I  A  D  A  R  S  Q  P  G  P  T  C  P  S  S  
 
181 GTCCAGGCCATCCTCTGCGACAATAGGTGTGGTAGATCAGCCTGTTCATACTACATAGAG 240   
      V  Q  A  I  L  C  D  N  R  C  G  R  S  A  C  S  Y  Y  I  E 
 
241 CGATGCGCCTGTTGTGCTAAATGCAACAGAATACCGTATTACGGAGCTAGCAACCATCCT 300   
      R  C  A  C  C  A  K  C  N  R  I  P  Y  Y  G  A  S  N  H  P  
 
301 GGACGCTGAAGGAGGAGGACCCACCCCCAGGAGAACTGACCCACTCACTATACACCGTTC 360   
      G  R  *   
 
361 ACATTAACTGGACAAATTAACTCTTTCAAAACCTGCATAGATTGTATTCAACTTCGAAAA 420   
421 TACCTAAAGAGGGTAAATTGAGATATGTATGACCCTAAGATACTAAGAGGTCCTTCCTAA 480   
481 GCTGAGTATAATAACAAGTAAATAGCATTAATAACTTATGAATGTAGTGATTCTGCTTAA 540   
541 AGAGTTGAACGTTTCCTCACAGTAACTCCTGAATGGTTCAATGTATGTCAATCTGTTCAC 600   
601 ATAATACAACAAACGTTCCTTATTATTCAACTACAAGGGACACATCACACCATACTGCTA 660   
661 ACCACTCATAAGCCCAGGACTTACTGCCATGTTAATATGAACGATGTATAGTGCGGTCCC 720   
721 GGGAGCTTGTGCTTTAATGTACCCTTTGCTTACGAGCAACCTTTTGCTGAGCTTGAGATA 780   
781 AAAATCGTCTAATGTTAGCCATTGAACAAATCAATCGTGGCTGCATAACTGGGTCAGTAT 840   
841 CTCTAACGTTCATTATGAAGCATAGCCATTTGTATTTTTGAATTCACTTTAAGCAGTACG 900   
901 GTATTATATAAGAAATATCATGATATAGAATACTCTTATAGTCTAAGGTCCATTTAATTA 960   
961 ATTTTATCATGTGTTTTAATAAAACGTATCATGTACGGAAAAAAAAAAAAAAAAAAAAAA  
1021 AAAA 1024  
 
Figure S1. Consensus nucleotide and amino acid sequences of contigs from EST library of 
king crab hemocytes; (A) contig 2 corresponded to paralithocin 1, (B) contig 16 corresponded 
to paralithocin 2 and (C) contig 11 corresponded to paralithocin 3. Pre-sequences are 
underlined and putative mature amino acid sequences are in bold. Cys residues are shaded in 
grey. Start and stop codons are doubled underlined and polyadenylation signal sequence 
(aataa) are shaded in black. The C-terminal amino acids cleaved off in the mature peptides are 
boxed. The sequences have been submitted to the Gene Bank with accession numbers 








Figure S2. TIC of paralithocin 1 (P23): (a) intact, (b) one reduced Cys-Cys, (c) two reduced 
Cys-Cys, (d) three reduced Cys-Cys, (e) all reduced Cys-Cys; paralithocin 2 (P30): (f) intact, 
(g) one reduced Cys-Cys, (h) two reduced Cys-Cys, (i) three reduced Cys-Cys, (j) all reduced 
Cys-Cys; paralithocin 3 (P34): (k) intact, (l) one reduced Cys-Cys, (m) two reduced Cys-Cys, 
(n) three reduced Cys-Cys, (o) all reduced Cys-Cys. Regarding monoreduced paralithocin 1 
(b) a contaminant of m/z 867.3, which is similar in mass to [M + 5H[5+ of paralithocin 1, was 
observed throughout the chromatographic run, which explain the poorly defined shape of the 
peak in question (tR 10.25 min). The TICs were recorded by an API4000 triple quadrupole 
mass spectrometer from ABSciex. 
